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C-bouton-type cholinergic afferents exert an important function in controlling
motoneuron (MN) excitability. During the immunocytochemical analysis of the role
of c-Jun in MNs with a monoclonal (clone Y172) antibody against phospho (p)-c-
Jun (serine [Ser]63), unexpected labeling was identified in the cell body cytoplasm.
As predicted for c-Jun in adult spinal cord, very few, if any MNs exhibited nuclear
immunoreactivity with the Y172 antibody; conversely, virtually all MNs displayed strong
Y172 immunostaining in cytoplasmic structures scattered throughout the soma and
proximal dendrites. The majority of these cytoplasmic Y172-positive profiles was closely
associated with VAChT-positive C-boutons, but not with other types of nerve afferents
contacting MNs. Ultrastructural analysis revealed that cytoplasmic Y172 immunostaining
was selectively located at the subsurface cistern (SSC) of C-boutons and also in the
inner areas of the endoplasmic reticulum (ER). We also described changes in cytoplasmic
Y172 immunoreactivity in injured and degenerating MNs. Moreover, we noticed that MNs
from NRG1 type III-overexpressing transgenic mice, which show abnormally expanded
SSCs, exhibited an increase in the density and size of peripherally located Y172-positive
profiles. A similar immunocytochemical pattern to that of the Y172 antibody in MNs was
found with a polyclonal antibody against p-c-Jun (Ser63) but not with another polyclonal
antibody that recognizes c-Jun phosphorylated at a different site. No differential band
patterns were found by western blotting with any of the antibodies against c-Jun or
p-c-Jun used in our study. In cultured MNs, Y172-positive oval profiles were distributed
in the cell body and proximal dendrites. The in vitro lentiviral-based knockdown of
c-Jun resulted in a dramatic decrease in nuclear Y172 immunostaining in MNs without
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any reduction in the density of cytoplasmic Y172-positive profiles, suggesting that the
synaptic antigen recognized by the antibody corresponds to a C-bouton-specific protein
other than p-c-Jun. Our results lay the foundation for further studies aimed at identifying
this protein and determining its role in this particular type of synapse.
Keywords: motoneuron, C-bouton, phospho-c-Jun, Y172 antibody, endoplasmic reticulum-plasma membrane
contacts
INTRODUCTION
Motor behavior is mediated by the voluntary contraction of
skeletal muscles, which are innervated by the distinct brainstem
and spinal cord motoneurons (MNs). In this regard, the
execution of complex movements, such as those involved in
locomotion, requires the cooperation and refined coordination
of different muscles, whose activation is modulated by intricate
neuronal circuits in the spinal cord. MNs play a crucial role in
these neuromodulatory circuits by adjusting their final motor
output and ensuring the accuracy of the movement. MN
activity is controlled by excitatory (mainly glutamatergic and
cholinergic) and inhibitory (mainly GABAergic and glycinergic)
inputs with supraspinal and intraspinal origins (Grillner, 2006;
Jordan et al., 2008). Cholinergic inputs are essentially represented
by so-called C-boutons, a type of synaptic terminal that contacts
the soma and proximal dendrites of α-MNs located in the
spinal cord and in cranial motor nuclei except those that
innervate extrinsic eye muscles (Conradi and Skoglund, 1969;
Connaughton et al., 1986; Davidoff and Irintchev, 1986; Nagy
et al., 1993; Hellström et al., 1999, 2003; Deardorff et al., 2014;
Witts et al., 2014; Rozani et al., 2019). C-boutons are large
nerve terminals (3–6 µm in diameter in humans and 1–8 µm
in rodents) that contain many densely packed clear spherical
or slightly flattened synaptic vesicles (Deardorff et al., 2014).
The postsynaptic counterpart of C-boutons exhibits a unique
and highly specialized structure, of non-well-defined function,
termed subsurface cistern (SSC), which is closely apposed to
the MN plasma membrane. In fact, SSC is a 10–15 nm-wide
and flattened lamella-like arrangement of the rough endoplasmic
reticulum (ER) located 5–8 nm below the postsynaptic
membrane (Conradi, 1969). Acetylcholine (ACh), released
by C-boutons as a neurotransmitter, binds to metabotropic
M2 muscarinic receptors postsynaptically located on MNs
(Hellström et al., 2003). Immunocytochemical studies have
revealed other molecules in addition to clusters ofM2muscarinic
receptors in the postsynaptic compartments of C-boutons; for
example Kv2.1 voltage-gated K+ channels (Muennich and Fyffe,
2004), Ca2+-activated K+ (SK) channels (Deardorff et al., 2013),
N-type Ca+ channels (Wilson et al., 2004), vesicle-associated
membrane protein 2 (VAMP-2; Hellström et al., 2003), sigma-1
receptors (S1Rs; Mavlyutov et al., 2012, 2013) and neuregulin-1
(NRG1; Gallart-Palau et al., 2014; Casanovas et al., 2017; Salvany
et al., 2019) are located postsynaptically at C-bouton synapses;
among thesemolecules, S1R, Kv2.1 andNRG1 accumulate within
the SSC in segregated regions, which probably represent distinct
spatial domains with high specificity (Gallart-Palau et al., 2014;
Casanovas et al., 2017; Salvany et al., 2019). In the lumbar
spinal cord, C-bouton inputs arise from a small cluster of
cholinergic interneurons (V0C interneurons) that express the
paired transcription factor Pitx2 and are located lateral to the
central canal (Zagoraiou et al., 2009). It has been reported
that the majority (∼70%) of the V0C interneurons project to
ipsilateral spinal MNs, whereas the remaining V0C cells project
to MNs located either on the contralateral side or on both
sides of the spinal cord (Miles et al., 2007). Studies performed
in mice have demonstrated that V0c and C-boutons have an
important role in the activation of specific hind-limb muscles
through the regulation of MN output in a task-dependent
manner (Zagoraiou et al., 2009). Thus, the neuromodulatory
activity of C-boutons appears to be critical in controlling
the excitation state of MNs, likely through reducing outward
K+ currents and, therefore, regulating after-hyperpolarization
(AHP) potentials (Miles et al., 2007; Deardorff et al., 2014;
Witts et al., 2014). In this regard, C-boutons would determine
the differences in intrinsic cellular excitability found in distinct
MN subtypes; MNs that innervate slow-twitch muscles (slow
[S] MNs) have a longer AHP latency after an action potential
and, consequently, a higher excitability and a slower firing
rate than that of MNs that innervate fast-twitch muscles [fast-
fatigable (FF MNs; for reviews, see Roselli and Caroni, 2015;
Nijssen et al., 2017]. It has been suggested that the intrinsic
hyperexcitability of S MNs confers resistance to degeneration,
while FF MNs are particularly vulnerable in MN diseases such
as amyotrophic lateral sclerosis (ALS) and spinal muscular
atrophy (SMA; Saxena et al., 2013; Roselli and Caroni, 2015;
Arumugam et al., 2017). Moreover, it has been shown that the
density of C-boutons is higher on FF MNs than on S MNs
(Hellström et al., 2003; Casanovas et al., 2017), and changes in
this type of synapse have been reported in murine models of
ALS (SOD1G93A mice) and SMA (SMN∆7 and Smn2B/− mice)
throughout the disease course (Pullen and Athanasiou, 2009;
Saxena et al., 2013; Gallart-Palau et al., 2014; Milan et al., 2015;
Cerveró et al., 2018).
The transcription factor c-Jun is a component of the AP-1
complex, and it has been reported to have a double function
as a regulator of both the death and survival (protection-
regeneration) of neurons (Herdegen et al., 1997). Thus, c-Jun
has been shown to participate in different processes, including
cell cycle regulation, cellular differentiation, organogenesis,
apoptosis and tumor transformation (Herdegen et al., 1997).
The phosphorylation of c-Jun at serine (Ser) 63 and/or 73,
a process mediated by c-Jun N-terminal kinases (JNKs),
strongly potentiates the capability of this factor to activate gene
transcription (Smeal et al., 1991, 1992, 1994; Waetzig et al., 2006;
Haeusgen et al., 2009). In this regard, it has been shown that JNKs
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are rapidly activated, promoting the increase of phospho (p)-c-
Jun levels following peripheral nerve injury or neuronal stress
in spinal MNs of neonatal and adult rats (Waetzig et al., 2006;
Yuan et al., 2010).
In immunocytochemical experiments performed with a
phospho-specific monoclonal, clone Y172, antibody against
c-Jun to examine its role in MN degeneration, we identified
unexpected cytoplasmic immunolabeling. Y172 antibody was
hosted in the rabbit and specifically detects c-Jun phosphorylated
on Ser63. Upon the application of this antibody to the spinal
cord from adult mice, nuclear immunoreactivity was found
in very few, if any, MNs. In contrast, the vast majority of
MNs exhibited prominent Y172 immunostaining in the form
of profiles widely distributed in the cytoplasm. Some of these
profiles were adjacent to the plasma membrane of the cell
body and proximal dendrites. This pattern of immunostaining
was only observed in large-sized MNs, presumably α-MNs,
but not in smaller MNs (γ-MNs) or interneurons. Due to
the restricted location of cytoplasmic Y172 immunoreactivity
in α-MNs and the synaptic-like appearance of Y172-positive
profiles located peripherally in cell bodies, we examined
their relationship with axon terminals contacting α-MNs
and found that Y172 immunoreactive profiles were closely
associated with C-boutons. This finding prompted us to analyze
in-depth the significance of the unusual immunoreactivity of
this antibody against the transcription factor c-Jun found in
MNs and the role that its association with C-boutons plays
in cholinergic synapse development and maintenance. We
examined the compartmentation of Y172 immunoreactivity and
its subcellular location in MNs. We analyzed the changes in
motoneuronal Y172-positive structures after peripheral nerve
injury and in murine models of ALS and SMA. We compared
Y172 immunolabeling in the spinal cord with that of other
polyclonal antibodies against p-c-Jun. Additionally, we analyzed
Y172 immunostaining in vitro in NSC-34 cells and spinal cord
MNs, in which we used RNA interference to knock down c-Jun.
MATERIALS AND METHODS
Animals and Surgical Procedures
All animal experimentation procedures were performed
according to the European Committee Council Directive and the
norms established by the Generalitat de Catalunya [published as
a law in the Diari Oficial de la Generalitat de Catalunya (DOGC)
2073, 1995]. All experiments were previously evaluated and
approved by the Committee for Animal Care and Use of our
university. Mice were housed in the University of Lleida Animal
Care Facility on a 12-h light/dark cycle with ad libitum access to
standard laboratory chow and water.
Several transgenic mouse lines were used in this study.
SOD1G93A (B6SJL-Tg(SOD1-G93A)1Gur/J) mice were
purchased from Jackson Laboratory (Sacramento, CA, USA)
and maintained as hemizygotes by breeding transgenic males
with C57BL/6 females. Smn2B/− mice were obtained by crossing
heterozygote male Smn gene knockout mice (Smn+/−; B6.Cg-
Smn1tm2Mrph/J, stock 007963; Jackson Laboratory, Bar Harbor,
ME, USA) with homozygote females with the 2B mutation
(Smn2B/2B; a kind gift from Dr. Rashmi Kothary, University
of Ottawa, Ottawa, ON, Canada; DiDonato et al., 2001); the
progeny of these transgenic mouse lines were identified by PCR
genotyping of DNA extracted from the tail by using specific
primers as described previously (Schrank et al., 1997; Cerveró
et al., 2018). Aged-matched wild-type (WT) littermates of the
transgenic animals were used as controls. Moreover, transgenic
mice overexpressing HA-tagged full-length NRG1 type III (HA-
NRG1FL type III, hereafter referred to as NRG1-III; Michailov
et al., 2004; Velanac et al., 2012) were also used. For experiments
in normal mice, nontransgenic CD1 animals (purchased from
Harlan Laboratories, Castellar del Vallès, Barcelona, Catalonia,
Spain) of different ages were used. Additionally, adult rats
[Sprague–Dawley, postnatal day (P) 60] and chick embryos
[Hy-line white, embryonic day (E) 20] obtained from fertilized
eggs (Avigan Terralta, Vinallop, Catalonia, Spain) incubated
in the laboratory were also used. The age of the chick embryos
was determined by reference to the Hamburger-Hamilton stage
series (Hamburger and Hamilton, 1992).
A group of CD1 mice was subjected to unilateral sciatic
nerve transection on P60. For this procedure, animals were
anesthetized with a combination of ketamine (100 mg/kg)
and xylazine (10 mg/kg), and the sciatic nerve at the femoral
level was exposed and transected. The proximal stump of
the transected nerve was ligated to prevent spontaneous
reinnervation. Postoperative analgesia was achieved by an
intraperitoneal (i.p.) injection of buprenorphine (0.05 mg/kg).
NSC-34 Cell Culture and Differentiation
The spinal cord × neuroblastoma hybrid cell line (NSC-34)
was obtained from CELLutions Biosystems Inc. (Cedarlane
Laboratories, Burlington; ON, Canada). NSC-34 cells were
maintained in a proliferation medium consisting of Dulbecco’s
modified Eagle’s medium (DMEM, Gibco, Waltham, MA,
USA) supplemented with 10% fetal bovine serum (FBS,
Gibco, Waltham, MA, USA), 0.25% penicillin/streptomycin
solution (Sigma-Aldrich, Saint Louis, MO, USA) and 2%
200 mM L-glutamine (Gibco, Waltham, MA, USA). Cells were
subcultured every 2–3 days.
For differentiation, cells were seeded in collagen (Sigma-
Aldrich, Saint Louis, MO, USA)-coated plates. A total of 12,000
NSC-34 cells/well were plated in 4-well culture dishes containing
collagen-coated round glass coverslips for immunocytochemical
analysis, and 120,000 NSC-34 cells/well were plated in 6-well
collagen-coated culture dishes for western blot analysis.
Twenty-four hours after seeding, the proliferation medium
was exchanged for fresh differentiation medium containing
1:1 DMEM/Ham’s F12 (Gibco, Waltham, MA, USA), 1% FBS
(Gibco, Waltham, MA, USA), 1% modified Eagle’s medium
nonessential amino acids (MEM NEAA, Gibco, Waltham, MA,
USA) and 1% penicillin/streptomycin (Sigma-Aldrich, Saint
Louis, MO, USA). Cells were maintained in the presence or
absence of retinoic acid (RA, 1 µM) in differentiation medium,
as previously described (Johann et al., 2011; Maier et al., 2013;
Madji Hounoum et al., 2016). The differentiation medium was
changed every 2 days. NSC-34 cells were allowed to differentiate
for up to 8 days to identify the optimal differentiation state.
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Following differentiation, two morphologically distinct cell
populations, namely, undifferentiated round-shaped cells with
small processes and cells with a more differentiated appearance
and long branches that resembled MNs, were observed. Every
2 days (2, 4, 6 and 8 days following differentiation), cell samples
were taken and processed for immunocytochemistry and western
blot analysis.
Spinal Cord MN Cultures
Purified primary cultures of spinal cordMNs fromE13 CD1mice
were prepared as previously described (Arce et al., 1999;
Gou-Fabregas et al., 2009) with some minor modifications.
Briefly, isolated MNs were plated in 4-well tissue culture dishes
coated with polyornithine/laminin (Sigma-Aldrich, Saint Louis,
MO, USA) for immunocytochemistry (20,000 cells/well) and
western blot analysis (50,000 cells/well). The culture medium
used was neurobasal medium (Gibco, Waltham, MA, USA)
supplemented with B27 (2% v/v, Gibco, Waltham, MA, USA),
horse serum (2% v/v, Thermo Fisher Scientific, Waltham,
MA, USA), L-glutamine (0.5 mM, Gibco, Waltham, MA,
USA), 2-mercaptoethanol (25 µM, Sigma-Aldrich, Saint Louis,
MO, USA), and a recombinant neurotrophic factor cocktail
containing brain-derived neurotrophic factor (BDNF, 1 ng/ml),
glial cell line-derived neurotrophic factor (GDNF, 10 ng/ml),
ciliary neurotrophic factor (CNTF, 10 ng/ml), cardiotrophin-1
(CT-1, 10 ng/ml), and hepatocyte growth factor (HGF, 10 ng/ml;
Gibco, Waltham, MA, USA). Twenty hours after plating,
aphidicolin (2µg/ml, Sigma-Aldrich, Saint Louis, MO, USA) was
added to the culture medium of some dishes and maintained
throughout the experiment. MNs were collected 3, 6 and 12 days
after seeding and processed for immunocytochemistry as well as
protein extraction.
Mixed primary cultures of the spinal cord from E13 CD1mice
were prepared as previously described (Roy et al., 1998). Briefly,
dissociated cells were plated at a density of 300,000 per well
in 4-well Nunclon Delta (Thermo Fisher Scientific, Waltham,
MA, USA) culture dishes containing round glass coverslips
coated with a poly-D-lysine plus Matrigel basement membrane
matrix (Corning, Bedford, MA, USA). The cells were then
maintained in minimum essential medium (Gibco, Waltham,
MA, USA) enriched with 5 g/l glucose and supplemented with
3% horse serum, 10 ng/ml nerve growth factor and B27 medium
(Gibco, Waltham, MA, USA). On day 6, the cultures were
treated with 1.4 µg/ml cytosine-β-arabinoside (Sigma-Aldrich,
Saint Louis, MO, USA) to minimize the growth of nonneuronal
cells. Cultures kept for 22–25 days in vitro were processed
for immunocytochemistry.
Plasmids and the Production of Lentiviral
Particles
For gene silencing experiments, small hairpin RNA
(shRNA) molecules were used. Constructs were generated
in pSUPER.retro.puro (Sigma-Aldrich, Saint Louis,
MO, USA) using specific oligonucleotides (Invitrogen,
Waltham, MA, USA) targeting the c-Jun sequence
(indicated by capital letters) as follows: shRNA
A6, gatccccAAAGGAAGCTGGAGCGGATttcaagagaATCCGC
TCCAGCTTCCTTTttttt (forward) and agctaaaaaAAAGGAAG
CTGGAGCGGATtctcttgaaATCCGCTCCAGCTTCCTTTggg
(reverse; targeting the 1715-bp region of the c-Jun mRNA
sequence); shRNA B4, gatccccAAGTCATGAACCACGTTAAtt
caagagaTTAACGTGGTTCATGACTTttttt (forward) and agct
aaaaaAAGTCATGAACCACGTTAAtctcttgaaTTAACGTGGTT
CATGACTTggg (reverse; targeting the 1874-bp region of the
c-Jun mRNA sequence); and shRNA C2, gatccccATCCGTTTG
TCTTCATTTTttcaagagaAAAATGAAGACAAACGGATttttt
(forward) and agctaaaaaATCCGTTTGTCTTCATTTTtctctt
gaaAAAATGAAGACAAACGGATggg (reverse) targeting the
150-bp region of the c-Jun mRNA sequence.
Adaptors for cloning the oligonucleotides into the
BglII/HindII sites of p-SUPER.retro.puro were added as
required. Escherichia coli (E. coli) DH5 cells were transformed
with the plasmid. When colonies appeared, they were selected,
sequenced to verify that they contained the desired sequence,
and purified. Lentiviral constructs were generated by digesting
pSUPER-sh with EcoRI and ClaI restriction enzymes to replace
the H1 promoter with the H1-short hairpin RNA (shRNA)
cassette in the pLVTHM lentiviral plasmid. The pLVTHM
vector contained green fluorescent protein (GFP) under the
control of an EF-1 alpha promoter for monitoring transduction
efficiency. The production of lentiviral particles was carried
out as previously described (Garcera et al., 2011). Lentiviruses
were propagated in human embryonic kidney 293T (HEK293T)
cells using the polyethyleneimine (Sigma-Aldrich, Saint Louis,
MO, USA) cell transfection method. Briefly, 20 µg of either
pLVHM-A6, pLVTHM-B4, pLVTHM-C2 or pLVTHM-EV
(empty vector, used as a control; hereafter referred to as EV),
13 µg of pSPAX2, and 7 µg of pMD2G were transfected into
HEK293T cultures (Zufferey et al., 1997). Cells were allowed to
produce lentivirus for 72 h. Then, the medium was centrifuged
at 1,000 rpm for 10 min, and the supernatant was filtered using
a 22-µm filter. The medium containing the lentiviruses was
stored at −80◦C. A 12-well dish plated with 20,000 HEK293T
cells per well was used to determine the biological titers of
viral preparations, which were expressed as the number of
transducing units per ml (TU/ml). After 48 h, the percentage
of GFP-positive cells was measured, and viruses were used for
the experiments at concentrations of 4 × 105–1 × 106 TU/ml.
For lentiviral transduction, MNs isolated from the spinal cord
of E13 CD1 mice were plated in 4-well dishes, as indicated
above. Four hours after seeding, medium containing lentivirus
(2 TU/cell) was added. The medium was changed 24 h later,
and the infection efficiency of each experiment was determined
by directly counting the GFP-positive cells. The vast majority
of cells were GFP positive, with a greater than 90% cell
transduction frequency (EV: 94.96% ± 0.50; A6: 96.63% ± 1.52;
B4: 96.28% ± 1.79; and C2: 93.89% ± 4.42: p > 0.05, one-way
ANOVA, post hoc Bonferroni’s test, 3 different experiments).
After 6 days in vitro (DIV), cells were collected and processed for
immunocytochemistry and western blot analysis.
Immunocytochemistry and Imaging
Spinal cords, brains and brainstems were obtained from
anesthetized mice that were transcardially perfused with 4%
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paraformaldehyde (PF) in 0.1 M phosphate buffer (PB), pH
7.4. Spinal cord samples were postfixed overnight in the same
fixative at 4◦C and then cryoprotected with 30% sucrose in
0.1 M PB containing 0.02% sodium azide. Serial transverse
cryostat sections (16-µm thick) of the lumbar region of the
spinal cord were collected on gelatin-coated glass slides and
stored at −80◦C. In some experiments, transverse spinal cord
sections (200-µm thick) were obtained with a vibratome,
collected in 0.1 M PB and transferred to a drop of PB placed
on Fisherbrand Superfrost Plus microscope slides (Thermo
Fisher Scientific, Waltham, MA, USA). A coverslip was then
applied to the tissue, which was squashed with forceps. The
preparations were then frozen in liquid N2, and after the
coverslip was removed, slides with retained tissue were fixed in
methanol at −20◦C for 10 min. Serial coronal sections (80-µm
thick) of the whole brain and brainstem were also obtained
with a vibratome and collected in 0.1 M PB. Cultured cells
plated on glass coverslips were fixed with 4% PF in 0.1 M
PB, pH 7.4 for 1 h at 4◦C. After washing with phosphate-
buffered saline (PBS), immunocytochemistry was performed as
described below.
For immunocytochemistry, tissue sections or cultured cells
were permeabilized with PBS containing 0.1% Triton X-100
for 30 min, blocked with either 10% normal goat serum or
normal horse serum in PBS for 1 h at room temperature, and
then incubated overnight at 4◦C with an appropriate primary
antibody mixture. The primary antibodies used were rabbit
monoclonal anti-phospho-c-Jun (serine [Ser]63) clone Y172
(diluted 1:300, hereafter referred to as the Y172 antibody;
Abcam, Cambridge, UK; cat. ab32385 or Millipore, Burlington,
MA, USA; cat.# 04-212); rabbit polyclonal anti-phospho-
c-Jun (Ser63; 1:100; Cell Signaling, Danvers, MA, USA;
cat.# 9261); rabbit polyclonal anti-phospho-c-Jun (Ser73;
1:100; Cell Signaling; cat.# 9164); guinea pig polyclonal
anti-synaptophysin 1 (1:500; Synaptic Systems, Goettingen,
Germany; cat.# 101004); guinea pig polyclonal anti-vesicular
acetylcholine transporter (VAChT; 1:500; Synaptic Systems,
Goettingen, Germany; cat.# 139105); guinea pig polyclonal
anti-vesicular glutamate transporter 1 (VGluT1, 1:500; Synaptic
Systems, Goettingen, Germany; cat.# 135304); guinea pig
polyclonal anti-vesicular GABA transporter (VGAT, 1:200;
Synaptic Systems, Goettingen, Germany; cat.# 131004); mouse
monoclonal anti-synaptic vesicle glycoprotein 2A (SV2, 1:1,000;
Developmental Studies Hybridoma Bank, Iowa City, IA, USA;
cat.# AB_2315386); mouse monoclonal anti-sigma-1 receptor
(S1R, 1:50; Santa Cruz Biotechnology, Dallas, TX, USA; cat.# sc-
137075); mouse monoclonal anti-Kv2.1 voltage-gated potassium
channel (Kv2.1, 1:100; NeuroMab, Davis, CA, USA; cat.# 73-
014); sheep polyclonal anti-choline acetyltransferase (ChAT,
1:1,000; Abcam cat.# Ab18736); rabbit polyclonal anti-ChAT
(1:200; Millipore, Burlington, MA, USA; cat.# AB143); rabbit
polyclonal anti-neuregulin-1 (NRG1) type III (extracellular,
1:250; Alomone labs, Jerusalem, Israel, cat.# ANR 113); mouse
monoclonal anti-NRG-CRD, type III, clone N126B/31 (1:250;
Millipore; cat.# MABN534); rabbit polyclonal anti-NRG1
1 α/β 1/2 (1:300; Santa Cruz Biotechnology, Dallas, TX,
USA; cat.# sc-348); mouse monoclonal anti-Golgi matrix
protein of 130 kDa (GM130, 1:200; BD Biosciences, San Jose,
CA, USA; cat.# 610822); mouse monoclonal anti-lysosomal
membrane glycoprotein (LAMP-1), clone ID4B (1:100;
Developmental Studies Hybridoma Bank, Iowa City, IA,
USA; cat.# ID4B); mouse monoclonal anti-KDEL (Lys-Asp-
Glu-Leu motif) receptor (KDELR), clone KR-10 (1:50; Stressgen
Biotechnologies, San Diego, CA, USA; cat.# VAA-PT048);
mouse monoclonal anti-protein disulfide-isomerase (PDI),
clone 1D3 (1:200; Enzo Life Sciences, Farmingdale, NY, USA;
cat.# ADI-SPA-891); and mouse monoclonal anti-calcitonin
gene-related peptide (CGRP; 1:100; Abcam, Cambridge,
UK; cat.# ab81887).
Once washed with PBS, the sections were incubated for
1 h with a combination of appropriate secondary fluorescent
antibodies labeled with one of the following fluorochromes
(1:500): Alexa Fluor 488, Alexa Fluor 546 (Molecular Probes,
Eugene, OR, USA), Cy3, or Cy5 (Jackson Immuno Research
Laboratories, West Grove, PA, USA). In some experiments,
DAPI (1:100; Sigma-Aldrich, Saint Louis, MO, USA) was also
added to stain the cell nuclei. Finally, the spinal cord sections
were counterstained with blue fluorescent NeuroTraceNissl stain
(1:150; Molecular Probes) and mounted using an anti-fading
medium containing 0.1 M Tris-HCl buffer (pH 8.5), 20%
glycerol, 10% Mowiol, and 0.1% 1,4-diazabicyclo[2, 2, 2]octane.
Immunocytochemical controls were achieved by the omission of
primary antibodies in parallel-processed sections resulting in no
detectable staining.
The slides were examined under a FluoView FV-500
or FluoView FV-1,000 Olympus laser scanning confocal
microscope (Olympus, Hamburg, Germany). For comparisons,
slides from different animals and experimental conditions
were processed in parallel for immunocytochemistry and
subsequent imaging. The same scanning parameters were used
for the acquisition of images corresponding to the different
experimental groups. Z-stack confocal images of MN cell bodies
(0.5–1-µm thick optical sections) were obtained.When required,
Z-stacks are displayed as maximum intensity projections.
Brain and brainstem sections that were incubated with the
Y172 antibody (1:1,000), were processed for immunoperoxidase
staining according to standard ABC procedures (Vectastain,
Vector, Burlingame, CA, USA). The sections were finally
mounted on gelatin-coated slides, air-dried, and coverslipped
with DPX. The sections were identified and mapped as described
in the Allen Reference Atlas (Dong, 2008).
Image and Morphometric Analysis
Digital images of the entire lumbar region were obtained
from every 30th section and analyzed with ImageJ software
(US National Institutes of Health, Bethesda, MD, USA). Only
fluorescent Nissl stained MNs exhibiting a large nucleus,
visible nucleolus, and large soma were analyzed. The area
and perimeter of MN somata were manually measured. The
number, area and fluorescent intensity of Y172-positive
profiles, and of profiles expressing the different proteins
examined and the degree of spatial association between them,
were evaluated in binarized images obtained from multiple
immunolabeled sections. Binarized Y172-positive profiles were
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used as a mask for measuring the immunostaining values
of other proteins after splitting multichannel images. For
immunofluorescence colocalization analysis, a plugin developed
for ImageJ by Pierre Bourdoncle (bourdoncle@ijm.jussieu.fr)
was used. In some cases, three-dimensional reconstructions
were performed using Bitplane (Imaris, Bitplane, CT, USA) on
a 0.5-µm-thick Z step obtained with a confocal microscope.
The digital images were edited using FV10-ASW 3.1 Viewer
(Olympus) and Adobe Photoshop CS4 (Adobe Systems Inc.,
San Jose, CA, USA). Although the investigators were not
blinded to the experimental condition, to minimize bias,
the MN selection for analysis was randomly performed
in the fluorescent Nissl channel. In this way, observers
were unaware of the pattern of immunostaining to be
analyzed in the complementary channels. Experiments
were examined by two independent investigators obtaining
similar results.
Electron Microscopy
Some mice were perfused with either 1% PFA and 1%
glutaraldehyde in 0.1 M PB (pH 7.4) for conventional electron
microscopy or with 4% PFA and 0.2% glutaraldehyde in 0.1 M
PB (pH 7.4) for immunoelectron microscopy.
For conventional electron microscopy, dissected tissues were
postfixed in 1% OsO4 and processed for Embed 812 embedding
(Electron Microscopy Sciences, Fort Washington, PA, USA)
according to standard procedures. Ultrathin sections were
counterstained with uranyl acetate and lead citrate.
For ultrastructural Y172 immunolabeling, pre-embedding
or post-embedding [freeze-substitution and low temperature
embedding in Lowicryl HM20 resin (Electron Microscopy
Sciences, Fort Washington, PA, USA)] procedures were used, as
previously described (Gallart-Palau et al., 2014). To facilitate the
localization of C-boutons in ultrathin cryosections, hypoglossal
MNs rather than spinal cord MNs were examined in some
cases. For this, brainstem or spinal cord samples were sectioned
(50-µm thick for pre-embedding and 200 µm thick for
post-embedding) with a vibratome, and the regions containing
either the hypoglossal nucleus or the spinal cord ventral horn
were microdissected.
Briefly, for pre-embedding immunolabeling, vibratome
sections were treated with 50 mM glycine in PBS for 30 min,
cryoprotected in 30% sucrose in 0.1 M PB and permeabilized
with four freeze/thaw cycles in liquid N2. The sections were
incubated overnight at 4◦C with the Y172 antibody (1:50; Abcam
or Millipore) and then for 1 h with an anti-rabbit biotinylated
antibody (1:100; Vector), visualized using Vectastain Elite ABC
(Vector), and incubated in a 0.05% 3,3-diaminobenzidine /0.01%
H2O2 mixture. Peroxidase reactive sites were further subjected
to silver enhancement to allow visualization by electron
microscopy. Briefly, sections were incubated in a solution
containing 2.6% hexamethylenetetramine (Merck, Darmstadt,
Germany), 0.2% silver nitrate (Merck, Darmstadt, Germany)
and 0.2% disodium tetraborate (Merck, Darmstadt, Germany)
for 10 min at 60◦C. The sections were then rinsed in distilled
water and treated with 0.05% gold chloride (Merck) in distilled
water for 2 min. Finally, the sections were rinsed, incubated
in 2.5% sodium thiosulfate (Merck, Darmstadt, Germany) for
2 min, postfixed with 2% OsO4 in cacodylate buffer for 1 h, and
dehydrated in a graded series of acetone. Labeled sections were
flat embedded in Embed 812, sectioned and counterstained with
uranyl acetate and lead citrate.
For post-embedding, ultrathin cryosections obtained with
a Leica EM FC cryo ultramicrotome (Leica Microsystems,
Wetzlar, Germany) were processed according to established
procedures (Tokuyasu, 1997; Slot and Geuze, 2007) and
double immunolabeled using the Y172 primary antibody (1:20;
Abcam or Millipore) and a mouse monoclonal anti-SR1
(1:10; Santa Cruz Biotechnology, Dallas, TX, USA) primary
antibody. After washing, the sections were incubated with 12-nm
gold-conjugated goat anti-rabbit IgG (1:30; Sigma-Aldrich,
Saint Louis, MO, USA) and/or 18-nm gold-conjugated goat
anti-mouse IgG (1:30; Sigma-Aldrich, Saint Louis, MO, USA).
Controls were achieved by omitting the primary antibody.
Observations were performed with a Jeol JEM 1400 (Jeol,
Tokyo, Japan) transmission electron microscope.
Western Blotting
Frozen spinal cords were fragmented and homogenized in
blending buffer 1× SR (2% SDS and 125 mM Tris-HCl, pH
6.8) supplemented with protease inhibitor (Sigma, cat.# P8340)
and PhosSTOP (Roche, Laval, QC, Canada). The homogenized
samples were then heated to 100◦C for 5 min and centrifuged
at 12,000 rpm for 5 min. The protein concentrations of
the supernatants were determined by BIO-RAD Micro DC
protein assay (BIO-RAD, Laboratories Inc., Hercules, CA, USA).
Loading buffer 4× SS (20% sucrose, 0.05% bromophenol blue,
and 0.1% sodium azide) containing 5–10% β-mercaptoethanol
(Sigma-Aldrich, Saint Louis, MO, USA) and 15 µg of
protein was then loaded onto a 10% or 15% polyacrylamide
electrophoresis gel. The proteins were electrotransferred to
PVDF (ImmobilonTM-P, Millipore, Burlington, MA, USA)
membranes in a Tris-glycine-methanol-buffered solution. The
membranes were then blocked with 5% dried skimmed
milk in 0.1% Tween 20 and Tris-buffered saline (TBST),
pH 8, for 1 h at RT and then extensively washed in
TBST. Immunodetection was performed by incubating the
membranes overnight at 4◦C with the following antibodies:
Y172 (1:1,000, Abcam or Millipore), rabbit polyclonal anti-
p-c-Jun (Ser63; 1:1,000; Cell Signaling, Danvers, MA, USA;
cat.# 9261); rabbit polyclonal anti-p-c-Jun (ser 73; 1:1,000;
Cell Signaling, Cell Signaling, Danvers, MA, USA; cat.# 9164);
rabbit monoclonal anti-c-Jun (1:1,000; Cell Signaling, Danvers,
MA, USA; cat.# 9165); and a mouse monoclonal anti-β-
actin, which was used as a loading control. The membranes
were washed in TBST, incubated for 60 min at RT with
the appropriate peroxidase-conjugated secondary antibodies
(1:5,000; AmershamBiosciences, Buckinghamshire, UK), washed
in TBST, and visualized using the ECL Prime Western
Blotting Detection Reagent Detection Kit (GE Healthcare,
Buckinghamshire, UK) following the procedure described by
the manufacturer. The quantification of band densities was
performed by a using Chemi-Doc MP Imaging System (BIO-
RAD Laboratories Inc., Hercules, CA, USA).
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Statistical Analysis
The data are expressed as themeans± standard error of themean
(SEM). Statistical analyses were performed by student’s t-test
or either one-way or two-way analysis of variance (ANOVA)
followed by post hoc Bonferroni’s test. The level of significance
was established at p≤ 0.05. GraphPad Prism 6 software was used
for statistical analysis and the graphical presentation of the data.
RESULTS
The Y172 Monoclonal Antibody Against
p-c-Jun Unexpectedly Immunolabels
C-Bouton Postsynaptic Sites in Spinal
Cord MNs
p-c-Jun immunostaining using a rabbit monoclonal anti-p-c-
Jun (Ser63) antibody clone Y172 (hereafter referred to as the
Y172 antibody) in combination with an antibody against ChAT
(the enzyme that catalyzes the synthesis of acetylcholine) as aMN
marker and fluorescent Nissl staining for neuron visualization,
was first analyzed in the lumbar spinal cord of adult (P75)
CD1 mice by confocal microscopy. Y172 immunolabeling was
observed in the form of a bright punctate pattern predominantly
distributed in the ventral horn gray matter and particularly in
a subpopulation of neurons showing large and angular-shaped
somata by Nissl staining (Figures 1A1–B). These Y172-positive
cells, which correspond to MNs based on their morphology
and location, had a mean cross-sectional area of 760.77 µm2
(± 40.52 [SEM]) and exhibited strong ChAT immunoreactivity
(Figures 1A1–D); all these features fit well with the previously
reported defining criteria of α-MNs (Shneider et al., 2009).
In contrast, smaller neurons (mean cross-sectional area of
254.25 ± 13.1 µm2) exhibited Y172-negative immunostaining
(Figures 1B–D) and were considered either γ-MNs (ChAT-
positive) or ventral interneurons (ChAT-negative; Shneider
et al., 2009). In large MNs, Y172-positive immunolabeling
was observed in granular structures of different sizes widely
distributed in the cytoplasm and in the form of conspicuous
puncta located in the periphery of the cell body (Figures 1G,H).
Y172 immunopositivity was found in the nucleus of a small
number (∼9%) MNs (Figure 1G); this is in agreement with the
findings of previous reports (Yuan et al., 2010), in which no
p-c-Jun-positive nuclei were detected in spinal MNs from adult
rats. In contrast, more than 95% of MNs displayed prominent
cytoplasmic p-c-Jun-like immunoreactivity upon application of
the Y172 antibody (Figures 1G,H). Image analysis showed that
∼38% of Y172-positive spots inMN somata also displayed strong
immunoreactivity for ChAT; moreover, the vast majority of
ChAT-positive spots (∼85%) exhibited Y172 immunoreactivity
as well (Figures 1E,F,H,I).
Due to the striking and unexpected pattern of
immunostaining obtained with the Y172 antibody, which had
not been previously described for other antibodies against p-c-
Jun, we decided to examine the changes in this immunostaining
during MN development in CD1 mice (Figures 2A1–E). On
E16 and E18, Y172-positive immunolabeling was observed in the
nuclei of ∼60% of MNs, but there was no detectable positivity
FIGURE 1 | p-c-Jun-like immunoreactivity of the Y172 antibody in spinal
cord MNs from adult CD1 mice (P75). (A1–A3) Representative confocal
images are taken from cryostat sections double immunostained with Y172
(green) and anti-ChAT (red) antibodies. Note the Y172 immunolabeling in
large-sized neurons in the ventral horn, which was immunostained for ChAT
as an MN marker; Y172 immunoreactivity was also seen in the ventral horn
gray matter around MNs. (B) Confocal micrograph obtained from a section
immunolabeled with the Y172 antibody (green) and counterstained with
fluorescent Nissl stain (blue) for neuron visualization. Note the selective
distribution of Y172-positive immunolabeling in large-sized neurons with an
angular-shaped cell body characteristic of MNs; smaller neurons, presumably
γ-MNs or ventral interneurons, were devoid of Y172 immunostaining. (C) The
soma size distribution of neurons showing either positive or negative
immunostaining with the Y172 antibody; 200 MNs from three different
animals were analyzed. Y172-positive and -negative neurons were fit to
Gaussian curves representing large and small populations, respectively. (D)
The average soma size of neurons exhibiting either positive or negative
immunoreactivity with the Y172 antibody obtained from the data shown in
(C); ***p < 0.001 vs. Y172+ immunoreactivity (IR), student’s t-test. (E,F) The
percentage of total Y172 positive profiles in the cytoplasm of MNs showing a
spatial association with ChAT-positive profiles (E), and ChAT-positive spots
also displaying Y172 immunoreactivity (F); Three hundred and 200 profiles
from 10 randomly selected MNs were analyzed in (E) and (F), respectively.
(G–I) Representative images of MNs double immunostained with Y172
(green) and anti-ChAT (red) antibodies. Note the pattern of
Y172 immunoreactivity in the form of positive spots of different sizes
distributed in the cytoplasm, with some immunolabeled profiles located in the
periphery of the cell bodies; most of the Y172-positive profiles, particularly
those located peripherally (i.e., the dotted-lined square), exhibited a spatial
association with ChAT, as shown in the higher magnification image (I).
Y172 immunolabeling was also observed in the nucleus of a limited number
of MNs (G). The data in the graph are expressed as the mean ± SEM. Scale
bars: A3 (valid for A1,A2) B = 30 µm; G,H = 10 µm; I = 2.5 µm.
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FIGURE 2 | Developmental changes in p-c-Jun-like-immunoreactivity with
the Y172 antibody in spinal cord MNs from E16-P30 CD1 mice. (A1–D2)
Representative confocal micrographs were taken from cryostat sections
immunolabeled with the monoclonal antibody (green) and counterstained with
(Continued)
FIGURE 2 | Continued
fluorescent Nissl stain (blue) for MN visualization. Note the selective nuclear
location of Y172-positive immunostaining in MNs at E16 (A1,A2); at P1, MN
cell bodies exhibited small cytoplasmic Y172-positive spots (arrows), which
coexisted with nuclear immunolabeling (B1,B2). At P15 and P30, the vast
majority of MNs did not exhibit nuclear immunostaining but showed abundant
Y172-positive patches widely distributed in the cell body cytoplasm and in the
ventral horn gray matter around MNs (C1–D2). (E) The time course of
developmental changes in Y172 immunoreactivity in MNs. The data are
expressed as the mean ± SEM; 8–14 randomly selected sections per spinal
cord from 3-4 different animals per age were analyzed. Scale bars:
A2,B2,D2 = 20 µm; C2 = 40 µm.
in the cytoplasm of the cell bodies (Figures 2A1,A2). On P1,
although the number ofMNs with nuclear Y172 immunostaining
was similar to that observed on E18, immunolabeled cytoplasmic
spots were also detected in more than 35% of MNs, and some
small positive puncta were found to be distributed in the ventral
horn gray matter (Figures 2B1,B2). During the postnatal period,
a drastic decrease in Y172 positivity was found in the nuclei of
MNs; thus, from P15 on, almost none of these cells exhibited
nuclear Y172 immunostaining (Figures 2C1,C2). The loss
of nuclear Y172 immunoreactivity correlated with a gradual
increase in immunoreactivity in the cytoplasm of MNs and
in the ventral horn gray matter; thus, on P30, the pattern of
p-c-Jun-like expression detected in MNs with the Y172 antibody
was similar to that observed in the adult (P75) mouse spinal cord
(Figures 2D1,D2, and compare with Figures 1A1–B). The time
course of these changes is shown in Figure 2E.
We next explored whether a similar pattern of
immunoreactivity can be observed with the same antibody
in other animal species, such as rats and chickens. In both
species, the Y172 antibody exhibited a comparable pattern of
immunostaining and distribution in MNs and spinal cord gray
matter as that seen in adult mice (Supplementary Figures
S1A1–D2).
Since the peripheral punctate pattern of p-c-Jun-like
immunolabeling in the cytoplasm of adult MNs obtained
with the Y172 antibody displayed clear similarities to the
distribution of afferent inputs on MN somata and proximal
dendrites, we performed double immunofluorescence analyses
by combining the Y172 antibody with an antibody against
synaptophysin (a marker of afferent synapses on MN somata
and proximal dendrites, Supplementary Figures S2A1–C).
Following confocal imaging and quantitative analysis, we found
that virtually all (99.13± 0.5, n = 31 MNs) Y172-positive profiles
peripherally located in MN somata were in close contact with
synaptophysin-positive puncta. We then assessed whether these
Y172-positive profiles were associated with a specific type of
afferent inputs by immunocytochemistry by combining the
monoclonal antibody with anti-VAChT, -VGluT1 and -VGAT
antibodies (for cholinergic C-type [C-boutons], glutamatergic
and GABAergic synapses, respectively; Figures 3A1–N). More
than 60% of total Y172-positive patches distributed in MN
somata showed a spatial relationship with VAChT-positive
presynaptic terminals (C-boutons), and nearly all (>90%) of
these VAChT-positive presynaptic terminals were associated
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with peripheral Y172-positive profiles (Figures 3A1–D,K,L); the
∼40% of Y172-positive spots in MNs that were not associated
with VAChT-positive signal mainly belonged to those more
internally located in the cell body, far from its periphery.
The percentages of peripheral Y172-positive profiles in MN
somata associated with VAChT-positive puncta, and vice
versa, are shown in Figure 3L. Colocalization and pixel profile
analysis in 1-µm-thick optical sections indicated that the
vast majority of peripheral Y172-positive spots were located
in front of and in close contact with presynaptic VAChT-
immunoreactive puncta, suggesting a potential function for the
Y172 antigen in cholinergic synapses (Figures 3A1–C); however,
both VAChT- and Y172-positive signals were not strictly
overlapped, indicating a clear spatial dissociation between
them. Following 3D reconstruction, we found that c-Jun-like-
containing structures closely complemented VAChT-containing
terminals, as expected for the postsynaptic location of the
Y172 signal (Figure 3D). We then examined age-related changes
in the number of peripheral Y172- and VAChT-positive puncta
in spinal cord MNs (Figure 3K) and noticed that they showed
a similar time course as that reported for other C-bouton-
associated proteins (Milan et al., 2015; Casanovas et al., 2017;
Salvany et al., 2019).
In contrast to the close relationship found between
Y172 immunolabeling and C-boutons, only a minor proportion
of total Y172-positive patches exhibited some association
with VGluT1 or VGAT afferent terminals (∼3.5% and ∼5%,
respectively; Figures 3E1–J,M,N); moreover, only ∼3.5% of
VGluT1-positive (Figure 3M) and ∼6% of VGAT-positive
(Figure 3N) puncta showed a certain degree of spatial
relationship with Y172-positive spots. In all cases, VGluT1-
and VGAT-immunoreactive terminals were distributed on the
surface of MN somata next to Y172-positive spots but never in
front of them, indicating that Y172-positive spots are exclusively
associated with cholinergic boutons. The fact that a minority
of Y172-immunostained puncta were very close to VGluT1-
and VGAT-containing boutons may have resulted in some
artifactual pixel overlapping after double immunolabeling.
Indeed, the pixel profile values along the line traced on the
spots exhibiting VGluT1 or VGAT immunoreactivity and those
showing Y172 positivity revealed a clear dissociation between
both signals (Figures 3G–J, for VGluT1, not shown for VGAT).
To further explore the relationship between
Y172 immunolabeling and C-boutons in MNs, spinal cord
sections from adult CD1 mice were incubated with the
monoclonal antibody together with specific antibodies
against S1R, Kv2.1 (two proteins known to be located at
the postsynaptic compartment of C-boutons) and VAChT
(Figures 4A1–H). We found that 65.55% (± 6.60, mean± SEM)
of S1R-immunostained spots and 86.39% (± 5.04) of Kv2.1-
immunostained spots were associated with Y172-positive puncta
(n = 224 S1R-containing puncta and 103 Kv2.1-containing
puncta from 8 and 6 MN somata, respectively). Pixel profile
analysis indicated an overlap between S1R and Kv2.1 signals
and Y172 immunostaining (Figures 4E–H), indicating that
all of them are distributed postsynaptically at C-boutons.
We described that SR1 and Kv2.1 reside in C-bouton SSC in
nonoverlapping microdomains in conjunction with NRG1
(Casanovas et al., 2017). As the anti-NRG1 antibody that
works well for C-bouton labeling is hosted in rabbits, double
immunolabeling with the Y172 and anti-NRG1 antibodies
was not feasible. However, by analyzing individual MNs
after single immunolabeling, we noticed that NRG1 and
the Y172 antigen did not share the same microdomain at
the C-bouton postsynaptic site. In fact, NRG1 clusters were
significantly larger than Y172-positive spots (NRG1: 7.15 ± 0.78
µm2; Y172: 1.98 ± 0.05 µm2; p < 0.001; n = 11 puncta per
condition in orthogonal projections) and displayed a reticular
micropunctate pattern compared to the more compact and
homogeneous appearance of Y172 puncta (Figures 4I,J).
We also explored whether specific labeling in spinal cordMNs
with the Y172 antibody is also present in cranial MNs. We found
that MNs from facial (CN VII), ambiguous (CNX), hypoglossus
(CN XII), and trigeminal (CNV) nuclei displayed an identical
punctate cytoplasmic pattern of Y172 immunoreactivity. This
appeared to sometimes be associated with a weak nuclear
Y172 signal, as expected for p-c-Jun. In contrast, MNs from
nuclei that innervate extrinsic ocular muscles, such as the
oculomotor (CN III), trochlear (CNIV), and abducens (CNVI)
nuclei, exhibited higher nuclear Y172 positivity, but the punctate
cytoplasmic pattern was virtually absent. This is consistent with
the described absence of C-bouton afferents in ocular MNs
(Hellström et al., 2003; Gallart-Palau et al., 2014). Neurons
located in nonmotor areas occasionally displayed nuclear
Y172 immunoreactivity without any clustered cytoplasmic signal
(Supplementary Figure S3).
Cellular Compartmentation of
Y172 Immunolabeling in Spinal Cord MNs
From CD1 Mice
To examine the cellular location and significance of
nonsynaptically associated Y172-immunoreactive cytoplasmic
spots, we performed immunofluorescent analysis by using the
monoclonal antibody in combination with specific antibodies
against different secretory pathway compartments, including
PDI (an ER chaperone responsible for the formation of disulfide
bonds in proteins, Perri et al., 2016), GM130 (a cis-Golgi
matrix protein that is involved in the maintenance of the
structure of the Golgi apparatus and in the fusion of vesicles
to its membrane, Nakamura, 2010), KDELR (a marker of the
intermediate compartment of the Golgi, Yamamoto et al., 2003),
CGRP (which accumulates in trans-Golgi stacks and secretory
vesicles, Calderó et al., 1992; Tarabal et al., 2001), and LAMP-1
[a major constituent of the lysosomal membrane (Eskelinen
et al., 2003); Figures 5A1–F]. As expected, all these antibodies
displayed an immunocytochemical pattern of fluorescent
patches of different sizes that were widely distributed in the
cytoplasm of MN cell bodies. Image analysis revealed that a high
percentage (∼75%) of patches immunoreactive for the Golgi
marker KDELR also exhibited Y172 positivity, whereas a lower
proportion (∼40%) of GM130-immunolabeled profiles were also
immunostained with the Y172 antibody. The great majority of
Y172-immunoreactive profiles usually displayed a larger contour
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FIGURE 3 | Immunocytochemical analysis of the spatial relationships between peripheral cytoplasmic Y172 immunolabeling and excitatory and inhibitory afferent
inputs to MNs of CD1 mice. Spinal cord sections were double immunostained with Y172 (green) and either anti-VAChT, VGluT1 or VGAT (for cholinergic,
glutamatergic or GABAergic synapses, respectively, all red) and processed for fluorescent Nissl staining for MN visualization (blue). (A1–A5) Representative maximum
intensity projections from confocal Z-stacked images showing Y172 and VAChT immunoreactivity in an MN of an adult (P75) mouse. Note the distribution of
Y172-positive spots in the cytoplasm of the cell body; while some immunoreactive patches were located around the nucleus, others were peripherally distributed
and exhibited a close association with VAChT-positive puncta. The area delimited by the dotted-lined rectangle in (A2) is shown at higher magnification in (A3–A5);
(Continued)
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FIGURE 3 | Continued
note that, while the peripherally located Y172-positive spot was in contact
with a VAChT-positive punctum, the spot that was more internally located did
not exhibit any association with VAChT immunolabeling. (B,C) Pixel profile
analysis (C) along a line crossing a multifluorescent-labeled
VAChT/Y172 synapse (shown in B) demonstrating the dissociation of
presynaptic VAChT immunostaining and postsynaptic Y172-positive staining;
the blue channel, corresponding to fluorescent Nissl staining, is not included
in the graph. (D) Volume rendering of a high magnification confocal image of
a C-bouton double immunolabeled with anti-VAChT (red) and
Y172 antibodies (green) demonstrating the nonoverlapping and separate
distribution of both signals; the blue channel corresponds to fluorescent Nissl
stain for MN visualization. (E1–F5) Representative Z-staked images showing
MNs immunostained with Y172 and either anti-VGluT1 (E1–E5) or anti-VGAT
(F1–F5) antibodies. Note that neither VGluT1- nor VGAT-containing puncta
were associated with Y172-positive profiles; the occasional degree of pixel
overlapping observed in some cases was due to the random close proximity
between Y172 and VGluT1 or VGAT immunoreactivity. (G–J) Pixel profile
analysis (H,J) along the lines depicted in (G,I); in (G), the yellow line delimits
the periphery of an MN by passing through different Y172- and
VGluT1-positive spots, whereas in (I), the lines cross two spots with
VGluT1 immunoreactivity (1, red) and one spot with Y172 immunoreactivity
(2, green); note the absence of colocalization between the two signals in
(H,J). (K) The time course of changes in the number of Y172- and
VAChT-positive profiles per 100 µm of soma perimeter in spinal cord MNs
from mice at different ages. (L–N) The percentage of peripheral Y172-positive
profiles closely associated with puncta positive for VAChT, VGluT1, or VGAT,
and vice versa, in adult (P75) MNs is shown in (L–N), respectively. The data
are expressed as the mean ± SEM; 200–300 profiles from 10 to 15 randomly
selected MNs (3–4 animals) per condition were analyzed; *p < 0.05 vs.
Y172+ immunoreactivity; student’s t-test. Scale bars: A1 = 10 µm (valid for
A2); D = 1 µm; E1,F1 = 10 µm (valid for E2,F2); F5 = 1.5 µm (valid for
A3–A5,E3–E5,F3,F4); G = 10 µm.
than those showing a KDLER- or GM130-positive signal.
Conversely, a smaller percentage of profiles expressing either
CGRP, the ER marker PDI or the lysosomal marker LAMP-1
(approximately 10%, 20% and 10%, respectively) also exhibited
some Y172 positivity (Figure 5F). These results suggest that the
vast majority of Y172-positive profiles are linked to structures of
the intermediate compartment of the Golgi containing KDELR,
which has been reported to recognize KDELmotif-containing
proteins and promote their retrograde transport from the Golgi
complex to the ER (Lewis and Pelham, 1990, 1992), and to
GM130, which is strongly attached to membranes of the cis-side
of Golgi stacks (Nakamura, 2010).
Ultrastructural Localization of
Y172 Immunoreactivity in MNs
To analyze the subcellular location of Y172 immunoreactivity
in MNs, ultrastructural analysis of the adult spinal cord and
hypoglossal MNs was performed. Hypoglossal MNs display
C-boutons that are more densely packed than and essentially
identical to those located in spinal cord MNs (Gallart-Palau
et al., 2014), facilitating C-bouton sampling in ultrathin sections.
The ultrastructural appearance of a C-bouton contacting a
spinal cord MN is shown in Figures 6A,B; as previously widely
described, C-bouton presynaptic terminals appeared to be filled
with small clear synaptic vesicles, whereas opposing postsynaptic
counterparts exhibited the corresponding SSC, located very
close to the MN membrane. High-resolution microscopy
was performed using pre-embedding (immunoperoxidase)
and post-embedding (immunogold staining on ultrathin
cryosections) procedures. In concordance with the results
obtained by light microscopy, ultrastructural immunolabeling
showed an exquisite Y172 positivity associated with the
postsynaptic region of C-boutons and to some intracellular
membrane compartments in MN somata (Supplementary
Figure S2). The highest resolution results were obtained by
the post-embedding cryo-immunogold procedure. In this case,
Y172-positive sites were clearly located at the cytoplasmic
surface of SSCs (Figures 6C,D). By double immunolabeling
for Y172 and the SSC marker S1R, it was observed that SSC
microdomains enriched in the Y172 antigen were segregated
from those in which S1R was concentrated (Figures 6E,F).
This indicates that the Y172 antigen shares the mosaic-like
distribution of other SSC-specific proteins (Deardorff et al.,
2013, 2014; Casanovas et al., 2017). In addition to being found
in synapses, Y172 positivity was also detected in particular ER
regions in the cytoplasm of MN cell bodies corresponding to
areas in which ER membranes displayed highly stacked motifs.
In contrast, ER regions showing more dispersed cisterns were
devoid of Y172 immunolabeling (Figure 6G). Gold particles
were found predominantly on the cytoplasmic face of ER stacks
(Figure 6H). Y172-immunoreactive sites were also observed to
be associated with some Golgi profiles and were predominantly
concentrated in some Golgi-associated vesicles (Figure 6I).
Changes in Y172 Immunoreactivity in MNs
After Peripheral Nerve Injury
Peripheral nerve interruption results in noticeable structural and
metabolic changes in axotomized MNs (Lieberman, 1971) that
are accompanied by a perineuronal glial reaction (Blinzinger
and Kreutzberg, 1968; Aldskogius and Kozlova, 1998), the
loss of proprioceptive inputs (Alvarez et al., 2011; Rotterman
et al., 2014), and increased neuronal excitability (Romer et al.,
2014). We (Casanovas et al., 2017; Salvany et al., 2019) and
others (Romer et al., 2014) have reported the disruption and
loss of cholinergic C-boutons and changes in their associated
molecules in axotomized MNs. Due to the close spatial
association between Y172 immunoreactivity and C-boutons, we
next studied whether the cholinergic deafferentation of MNs
induced by peripheral nerve injury is accompanied by changes
in the immunocytochemical pattern observed upon staining
with the Y172 antibody. It is known that, in adult MNs,
axotomy provokes the rapid upregulation of c-Jun (Jenkins
and Hunt, 1991; Wu et al., 1994), which is assumed to be
associated with nerve regeneration (Ruff et al., 2012). The
phosphorylation of c-Jun at Ser-63 and/or Ser-73 enhances its
transcriptional activity (Dérijard et al., 1994; Smeal et al., 1994),
and it has been reported that root avulsion, but not distal
axonal lesion, induces the phosphorylation of this transcription
factor in adult rat MNs (Yuan et al., 2010). We performed
unilateral sciatic nerve transection and analyzed p-c-Jun-like
immunoreactivity with the Y172 antibody on different days
following lesion; this antibody was combined with antibodies
against VAChT and IBA1 to identify C-boutons and microglia,
respectively (Figures 7A1–G4). Axotomized MNs can be
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FIGURE 4 | Y172 immunoreactivity colocalizes with S1R and Kv2.1 in C-boutons. (A1–D4) Representative confocal images of adult (P75) mouse spinal cord MNs
double immunostained with antibodies against either S1R or Kv2.1 (red) and Y172 (green), as indicated in the panels; sections were counterstained with fluorescent
Nissl stain (blue) for MN visualization. The areas delimited by dotted-line squares in (A4,C4) are shown at higher magnification in (B1–B4,D1–D4), respectively. (E–H)
Pixel profile analysis (F,H) along the lines depicted in (E,G), which were obtained from MNs immunolabeled with Y172 (green) and anti-S1R or Kv2.1 (red) antibodies;
fluorescent Nissl staining (blue) for MN visualization can be seen in (E). Note the overlap between the Y172 and S1R (F) or Kv2.1 (H) signals. (I,J) Squashed MNs
immunolabeled with anti-NRG1 (I) and Y172 (J) antibodies; the circled profiles are shown at higher magnification in the insets; note that Y172-positive profiles were
smaller and displayed more compact patterns than NRG1 clusters. Scale bars: A4,C4 = 10 µm (valid for A1–A3,C1–C3); B4,D4 = 1 µm (valid for B1–B3,D1–D3);
G = 1 µm (valid for E); and J = 20 µm (valid for I).
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FIGURE 5 | Nonsynaptically associated cytoplasmic Y172 immunoreactivity in MNs is mainly located in secretory pathways (s.p.). (A1–E7) Representative confocal
micrographs of adult (P75) mouse MNs in spinal cord sections double immunostained with the Y172 antibody (green) and for different intercellular compartment
markers (red) including PDI, GM130, KDELR, CGRP, and LAMP1 (as indicated in the panels); sections were counterstained with fluorescent Nissl stain (blue) for MN
visualization. The areas delimited by dotted-line squares in (A3–E4) are shown at higher magnifications in (A5–E7). (F) The percentage of Y172-positive puncta that
colocalized with the different markers of secretory pathway compartments. The data are expressed as the mean ± SEM; 200–300 Y172-positive profiles in
10 randomly selected MNs from three mice were analyzed. Scale bars: E4 = 10 µm (valid for A1–E3); E7 = 1 µm (valid for A5–E6).
recognized since they are enwrapped by abundant reactive
microglia, which display apparent positive chemoattraction to
C-boutons (Casanovas et al., 2017). Twenty-four hours after
axotomy, the ipsilateral side of the spinal cord exhibited
numerous MNs showing positive nuclear Y172 immunostaining
and increased IBA1 immunolabeling indicative of reactive
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FIGURE 6 | Ultrastructural localization of Y172 immunogold staining in the
spinal cord and hypoglossal MNs of adult (P75) mice. (A,B) A C-bouton on a
spinal cord MN cell body (shaded in red) observed by the electron microscopy
after conventional processing; presynaptic terminals (shaded in green) were
filled with small clear synaptic vesicles and some mitochondria. Adjacent and
closely associated with the postsynaptic membrane, a flattened cistern of the
endoplasmic reticulum (ER; shaded in blue), corresponding to the subsurface
cistern (SSC), was observed (more detailed in B); the intersynaptic
extracellular space is shaded in yellow. (C,D) A C-bouton detected in an
ultrathin cryosection of an MN after double immunolabeling with different
sizes of nanogold particles depicted at middle magnification. To facilitate the
identification of C-bouton synaptic organization in a less structurally defined
cryosection, compare (C,D) with (A,B). Note also the accumulation of gold
particles representing Y172 immunoreactivity at the postsynaptic region of
the C-bouton (shaded in red). (E,F) A higher magnification image showing a
double immunogold labeling of a C-bouton synaptic site using the
Y172 antibody (red arrows) and an anti-S1R antibody as SSC marker (blue
arrows), visualized with 12-nm and 18-nm particles, respectively. To facilitate
the localization of the immunolabeling, the coloring of the synaptic
subcompartments in (F) is the same as that in (A,B); Y172 antibody
immunoreactivity was located on the outer surface of SSC membrane (red
arrows) and clustered separately from S1R immunoreactivity (blue arrows).
(G,H) Y172 immunoreactivity was also associated with stacked membrane
sheets of the ER (delimited by red dashed lines); other ER regions containing
less compact cisterns (∗) were devoid of labeling. (H) A detailed image of the
ER (delimited by the white dashed-line rectangle in G) immunolabeled with
the Y172 antibody revealed that gold particles were mainly associated with
the external surface of the ER membranes. (I) Y172 immunolabeling was also
observed in vesicles (delimited by the red dashed circle) adjacent to the Golgi
apparatus (∗). Scale bars: A–F = 200 nm; G = 500 nm; H,I = 100 nm.
microgliosis (Figures 7A1–D5). In axotomized MNs, the
appearance of nuclear Y172 positivity was accompanied by
a rapid reduction (∼65%, 7 days post-axotomy) in both
the density and size of cytoplasmic Y172-immunostained
profiles (Figures 7H,I) and an enhancement of the recruitment
of activated microglial cells around MN somata. At later
time-points (14–180 days), the Y172-positive signal persisted in
the nucleus but was barely detectable in the cell body cytoplasm
of the vast majority of axotomized MNs (Figures 7F1–F4).
The lack of cytoplasmic Y172-positive profiles in long-term
axotomized MNs (i.e., 30–180 days) differed from their
abundance in apparently nonaxotomized MNs, which did not
exhibit a nuclear Y172-positive signal (Figures 7G1–G4). The
time course of changes in the density and size of Y172-positive
spots after axotomy are shown in Figures 7H,I. Compared with
the progressive loss of C-boutons in MNs following nerve injury
(Figure 7J), the disappearance of cytoplasmic Y172-positive
profiles occurred more abruptly; thus, axotomized MNs showing
very scarce spots immunostained with the Y172 antibody
(e.g., 30 days after lesion) still maintained numerous VAChT-
positive puncta on the cell body (compare Figure 7H with
7J). This indicates a clear dissociation between changes in
structures exhibiting a Y172-positive signal and cholinergic
deafferentation that occurred in injured MNs. Nevertheless,
180 days post-axotomy, ∼60% of scarce cytoplasmic spots
showing Y172 positivity in some axotomized MNs still
maintained a spatial association with VAChT-immunoreactive
puncta (ipsilateral side: 58.1% ± 11.8; contralateral side:
68.3% ± 4.42; n = 32 and n = 176 Y172-positive profiles from
5 and 7 MNs, respectively; p> 0.05, student’s t-test).
Y172 Immunoreactivity in MNs
Overexpressing NRG1 Type III Isoform
NRG1 is a prominent component of C-boutons that specifically
accumulates in SSCs of spinal MNs (Gallart-Palau et al., 2014;
Casanovas et al., 2017). Studies performed by our group in
transgenic mice overexpressing different NRG1 type isoforms
have revealed that NRG1 type III acts as a specific organizer of
SSC-like structures, whereas NRG1 type I promotes cholinergic
synaptogenesis on MNs (Salvany et al., 2019). Here, we took
advantage of mice overexpressing N-terminally HA epitope-
tagged full-length NRG1 type III (NRG1-III; Velanac et al.,
2012) to examine whether changes in NRG1 type III expression
can influence Y172 immunoreactivity in MNs. We previously
reported that NRG1 type III overexpression results in the
accumulation of unprocessed NRG1 type III at the postsynaptic
sites of C-boutons. This is accompanied by an expansion of
surface-associated ER membranes in the form of redundant
SSCs and the augmented expression of the SSC-associated
molecules S1R and Kv2.1 and postsynaptic membrane-linked
M2 muscarinic receptors; conversely, no changes in the
density of cholinergic (VAChT-positive) C-boutons have been
observed following NRG1 type III overexpression (Salvany
et al., 2019). In the present experiments, we corroborated
these findings (not shown) and detected significant changes
in Y172 immunolabeling. Whereas the density of total
cytoplasmic Y172-positive profiles was dramatically reduced
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FIGURE 7 | Changes in Y172 immunoreactivity in axotomized MNs. The
sections of the spinal cord from adult (P60) mice subjected to unilateral sciatic
nerve transection were immunostained with the Y172 antibody in
combination with antibodies against VAChT (blue) and IBA1 (red), as indicated
in the panels, to identify C-boutons and microglia, respectively; sections were
also counterstained with fluorescent Nissl stain for MN visualization (shown in
gray in F4,G4). (A1–B2) Ventral horn MNs in general view (A1–B2) and higher
magnification (C1–E5) images from the contralateral (contra., nonaxotomized,
A1, A2,C1–C5) and ipsilateral (ipsi., axotomized, B1, B2,D1–E5) sides of the
spinal cord 1 (A1–D5) and 14 (E1–E5) days after nerve transection; note the
nuclear Y172 immunostaining (B1,D1,E1) and the prominent IBA1-positive
reactive microglia on the ipsilateral side (B2, D4,E4) in relation to those on the
contralateral side (A1,A2,C1,C4); in (E1), an MN with intense nuclear
Y172 staining as well as numerous profiles immunoreactive with the
monoclonal antibody can be seen. The areas delimited by dotted-line
rectangles in (C4,D4,E4) are shown at higher magnifications in (C5,D5,E5);
note, on the ipsilateral side (D4,E4), the presence of abundant IBA1-positive
microglial processes enwrapping MNs and contacting Y172-positive profiles,
suggesting a role for microglia in the loss of peripheral cytoplasmic
(Continued)
FIGURE 7 | Continued
Y172 immunolabeling in axotomized MNs. (F1–G4) MNs on the ipsilateral
side of spinal cord 30 (F1–F4) and 180 (G1–G4) days after axotomy; note in
(F1–F4) the intense nuclear signal and the depletion of cytoplasmic peripheral
profiles positive with the Y172 antibody. In (G1–G4), an apparently healthy
MN exhibiting both abundant cytoplasmic profiles and the absence of nuclear
immunostaining with the Y172 antibody can be seen in the vicinity of an
atrophic MN showing intense nuclear Y172 immunoreactivity. In all cases,
MNs with nuclear Y172 signal displayed a reduced density of VAChT-positive
C-boutons. (H,I) The density (per 100 µm2 of cell body) and size (in µm2) of
cytoplasmic Y172-positive profiles in MNs located on the contralateral and
ipsilateral sides of the spinal cord on different days after unilateral sciatic
nerve transection. (J) Changes (expressed as the % of the contralateral side)
in the density of VAChT-positive puncta observed in ipsilateral side MNs on
different days post-axotomy. The data in the graph are expressed as the
mean ± SEM, *p < 0.05 and ***p < 0.001 vs. the contralateral side;
n = 8–11 randomly selected MNs per side from three mice per day
post-axotomy. Scale bars: B2 = 40 µm (valid for A1–B1); E4 = 20 µm (valid
for C1–C4,D1–D4,E1–E3); E5 = 5 µm (valid for C5,D5,E5); G4 =10 µm (valid
for F1–G3).
in NRG1 type III-overexpressing MNs (Figure 8A), these
MNs exhibited a marked increase in the density of peripheral
Y172-positive spots compared to those exhibited by MNs from
WT animals (Figure 8B). Moreover, Y172-positive profiles
located in the periphery of NRG1 type III-overexpressing MN
somata displayed a morphological pattern of enlargement
(Figures 8C,D; see also Figures 8G1–H3), which correlated
with the redundancy and expansion of SSC structures we
previously described in this paradigm (Salvany et al., 2019).
Colocalization analysis of the Y172 signal with either VAChT-
or NRG1 type III-immunolabeling was performed in MNs
from NRG1 type III-overexpressors and WT mice. We found
that, in NRG1-type III-overexpressing MNs, the percentage of
Y172-positive patches showing close contact VAChT-containing
puncta was dramatically reduced (Figure 8E), whereas the
proportion of Y172-positive patches associated with NRG1 type
III-positive profiles was markedly increased (Figure 8F). These
results indicate that an abnormal expansion of the SSC, such as
that which occurs in NRG1 type III-overexpressing MNs, results
in elevated Y172 immunoreactivity, presumably concentrated
in its enlarged cisterns. Although closely related, NRG1 and the
Y172 antigen appear to be clearly segregated in a mosaic-like
form in SSCs.
Y172 Immunoreactivity in Diseased MNs
We and others have reported that changes in C-boutons occur
in murine models of the MN diseases ALS (SOD1G93A mice) and
SMA (SMN∆7 and Smn2B/− mice; Pullen and Athanasiou, 2009;
Saxena et al., 2013; Gallart-Palau et al., 2014; Milan et al., 2015;
Cerveró et al., 2018). Here, we wanted to examine whether similar
changes in Y172 immunoreactivity also occur in these paradigms.
Spinal cord sections from mutant SOD1G93A and Smn2B/−
mice and their respective WT littermates were examined
following double immunostaining with the Y172 antibody and
an anti-VAChT antibody.
SOD1G93A mice exhibit the first clinical symptoms of disease
on approximately P90 and die by approximately P120 (Turner
and Talbot, 2008). In these animals, a gradual decrease in
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FIGURE 8 | Changes in Y172 immunoreactivity in MNs from mutant mice (P60) overexpressing NRG1 type III. (A–F) The density (per 100 µm2 MN soma, A,B) and
size (in µm2, C,D) of total (A,C) and peripheral (periph., B,D) Y172-positive profiles and the percentage of these profiles showing a spatial association with
VAChT-positive C-boutons (E) and NRG1 type III-positive spots (F) in MNs from WT and NRG1 type III-overexpressing mice. Note that NRG1 type III overexpression
was associated with a prominent decrease in the density of total Y172-positive profiles (A) and a significant increase in the number of those located peripherally (B)
in MNs; the area of both total and peripheral Y172-positive profiles was dramatically increased in MNs from NRG1 type III-overexpressing animals (C,D). Additionally,
the percentage of Y172-positive profiles showing a close association with VAChT- (E) or NRG1 type III-positive (F) spots significantly increased or decreased,
respectively, in MNs from NRG1 type III-overexpressing animals; 10–15 randomly selected MNs from 3 to 4 mice per condition were analyzed; *p < 0.05 and
***p < 0.001 vs. WT; student’s t-test). (G1–G4) Representative confocal micrographs of an NRG1 type III-overexpressing MN immunostained with Y172 (green) and
anti-NRG1 type III (red) antibodies and counterstained with fluorescent Nissl stain (blue) for neuron visualization. Note that, compared to MNs of adult CD1 mice (see,
for instance, Figure 1 or Figure 3), MNs overexpressing NRG1 type III exhibit an enlargement of Y172-positive profiles located in the periphery of the cell body,
which correlated with the redundant and expanded SSCs previously described in Salvany et al. (2019); note also the expansion of NRG1 type III immunolabeling
peripherally located in MN soma. (H1–H3) A higher magnification image of the area delimited in (G4) by the dotted-line rectangle corresponding to Y172, NRG1 type
III and merged channels, as indicated, is shown. Scale bars: G4 = 10 µm (valid for G1-G3); H3 = 2.5 µm (valid for H1, H2).
the density of peripheral Y172-positive profiles was found
in MNs as the disease progressed (Figures 9A,D1–H3).
Compared to that in age-matched WT mice, the number of
Y172-immunoreactive spots was already decreased in MNs
from SOD1G93A animals on P60, well before symptom onset.
Interestingly, at this age in the mutant mice, apparently healthy
MNs exhibiting abundant cytoplasmic Y172-positive profiles
were located in the vicinity of degenerating MNs surrounded by
IBA1-positive microglia (Figures 9D1–D4); these degenerating
MNs displayed high nuclear Y172 immunoreactivity and
very scarce cytoplasmic Y172-immunostained profiles. A
more dramatic depletion of Y172 immunolabeling was
observed in SOD1G93A MNs on P90 and, particularly, on
P120 (∼50% and 60%, respectively). Again, at these time
points, SOD1G93A MNs that were degenerating and showed
intense Y172 immunoreactivity in their nuclei were those that
exhibited scarce immunoreactive cytoplasmic profiles; these
MNs alternated with MNs that displayed apparently healthy
morphology and profuse cytoplasmic Y172 immunolabeling.
As expected from our previous analysis (Gallart-Palau et al.,
2014), the density of VAChT-immunostained C-boutons
in SOD1G93A MNs on P120 was considerably reduced
(∼35% reduction) compared to that in age-matched WT
MNs (Figure 9B); this C-bouton loss in MNs from mutant
animals was not noticed on either P60 or P90 (not shown)
despite the depletion in Y172-positive profiles found at
both time-points of the disease. The number of VAChT-
positive puncta that showed a spatial association with the
Y172 signal was then quantified on P120. At this age, we
found that there was a significant decrease (∼45%) in the
proportion of SOD1G93A MNs exhibiting VAChT/Y172-
positive puncta, compared to that found in WT MNs
(Figures 9C,F1–H3).
Similar results were obtained in an intermediate model of
SMA, the Smn2B/− mouse. Smn2B/− mice develop a moderately
severe form of SMA and exhibit phenotypic alterations starting
at ∼P12 and a mean lifespan of ∼3–4 weeks (Eshraghi
et al., 2016; Cerveró et al., 2018). Compared to that in WT
littermates, the density of peripheral Y172-positive profiles
was already slightly reduced in MNs from Smn2B/− mice
on P5 (Figure 10A), an age at which significant MN death
has been described in this mouse model (Cerveró et al.,
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FIGURE 9 | Changes in Y172 immunoreactivity in MNs of SOD1G93A mice. (A–C) The density (number per 100 µm of soma perimeter) of peripheral Y172-positive
profiles (shown as the % of WT, A) and of VAChT-positive puncta (B), and the percentage of VAChT-positive puncta closely associated with Y172-positive profiles
(C) in WT and mutant MNs at different stages of disease (presymptomatic [P60], early symptomatic [P90], and end-stage [P120]). The data are expressed as the
mean ± SEM; 15–22 MNs randomly selected from SOD1G93A animals and respective WT littermates were analyzed; *p < 0.05, **p < 0.01 and ***p < 0.001 vs. WT,
student’s t-test. (D1–E4) Representative confocal micrographs of spinal cord sections from SOD1G93A mice at the presymptomatic (P60, D1–D4) and end (P120,
(Continued)
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FIGURE 9 | Continued
E1–E4) stages of disease immunostained with Y172 (green), anti-IBA1 (for
microglia, red) and anti-VAChT (for C-boutons, blue) antibodies, as indicated
in the panels; sections were also counterstained with fluorescent Nissl stain
(blue in D4) for MN visualization. Note the presence of two MNs (delimited
with dotted lines in D3), one of them exhibiting a normal appearance with
abundant Y172-positive profiles widely distributed in the cell body cytoplasm
and another with a typical appearance displaying intense nuclear labeling with
the Y172 antibody and almost a complete absence of cytoplasmic profiles
immunostained with this antibody, in (D1–D4); there were numerous
IBA1-positive microglial processes around the second type of MN,
suggesting incipient degenerative changes. Prominent reactive microgliosis
found around degenerating MNs exhibiting nuclear Y172 immunostaining in a
P120 SOD1G93A mouse is shown in (E1–E4). (F1–F4) A spinal cord MN from
a SOD1G93A mouse at end-stage (P120) showing strong nuclear
Y172 immunoreactivity (green) but depletion of cytoplasmic profiles
immunostained with the Y172 antibody; this MN, however, still exhibited
abundant VAChT-positive C-boutons (red), with the vast majority of them not
displaying any association with the scarce Y172-positive profiles remaining.
VAChT-positive C-boutons delimited with dotted-line squares in (F3; indicated
as 1 and 2) are shown in (G1–G3) (1) and (H1–H3) (2); C-bouton number
1 was associated with a small remnant Y172-positive signal, whereas,
Y172-immunoreactivity was completely lost in C-bouton number 2. Scale
bars: D4,E4 = 20 µm (valid for D1–D3,E1–E3, respectively); F4 = 10 µm
(valid for F1–F3); H3 = 1 µm (valid for G1–H2).
2018). The depletion of Y172-positive profiles in Smn2B/−
MNs was more pronounced at advanced stages of disease
(P20-P30; Figures 10A,D1–E4), coinciding with the loss of
∼75% of the number of MNs present in WT mice (Cerveró
et al., 2018). In contrast, the density of VAChT-positive
puncta in Smn2B/− MNs was not noticeably changed until
the end stage of disease (P25–30; Figures 10B,D1–E4; see
also Cerveró et al., 2018), when we also observed significantly
less C-boutons with a spatial relationship with peripheral
Y172-positive spots (Figure 10C).
The Specificity of Synaptically Associated
p-c-Jun-Like Immunoreactivity Revealed
by the Y172 Antibody
Due to the unexpected close association between VAChT-
containing synapses and the phosphorylated transcription
factor c-Jun found with the Y172 antibody, we decided to
analyze whether reproducible results could be obtained with
other distinct anti-p-c-Jun antibodies. Two rabbit polyclonal
antibodies against c-Jun phosphorylated either at Ser63 or
at Ser73 were tested in spinal cord sections from adult mice
under basal conditions and after the induction of MN stress,
such as that provoked by peripheral nerve axotomy. For the
latter condition, samples from mice were examined 30 days
after sciatic nerve transection. Under basal conditions, the
immunofluorescence obtained with the polyclonal antibody
against p-c-Jun (Ser63) was hardly visible when confocal
images were captured using the same scanning parameters
as those utilized for the Y172 antibody. However, when
the microscopy settings were modified to attain a higher
sensitivity for detection, the polyclonal antibody exhibited an
immunocytochemical pattern similar to that obtained with
the Y172 antibody (Figures 11A1–A4). As expected for p-c-
Jun, in sections from the lumbar spinal cord of axotomized
mice, strong nuclear immunoreactivity was found in most
MNs (Figures 11B1–B4). The cytoplasmic spot pattern of
immunolabeling found with the Y172 antibody under basal
conditions was barely visible with the rabbit polyclonal anti-p-c-
Jun (Ser63) antibody in axotomized animals, even after detector
optimization (Figures 11B1–B4). This result is consistent with
the progressive loss of cytoplasmic p-c-Jun (Ser63) expression
observed in axotomized MNs with the Y172 antibody. In
contrast with the findings observed with the polyclonal
anti-p-c-Jun (Ser63) antibody, the antibody raised against
p-c-Jun (Ser73) displayed negative nuclear and cytoplasmic
immunostaining under basal conditions (Figures 11C1–C4).
However, this antibody showed intense immunoreactivity
in the nucleus of axotomized MNs (Figures 11D1–D4).
Overall, these results indicate that synaptically associated
p-c-Jun-like immunoreactivity is a property shared only by
Ser63 phosphospecific antibodies. This raises the question of
whether the antigen detected by these antibodies belongs to an
unknown protein that shares a common phosphospecific epitope
with c-Jun.
We next examined whether the Y172 antibody is able to detect
proteins other than p-c-Jun (Ser63) in spinal cord extracts by
western blot analysis. We compared the protein band pattern
detected by the Y172 antibody with that identified with the other
abovementioned antibodies against p-c-Jun and, also, against
c-Jun (Figures 11F,G). The Y172 antibody detected a protein
∼43–48 kDa in size, as expected for p-c-Jun. This band was also
observed with the polyclonal antibodies against p-c-Jun (Ser63)
and p-c-Jun (Ser73). A band with a similar molecular weight
was also recognized by the polyclonal anti-c-Jun antibody. The
obvious similarities between the western blot patterns obtained
with the distinct antibodies used indicate that the differences in
the cellular pattern (i.e., C-bouton-associated immunostaining)
observed with the Y172 antibody do not correlate with any
detectable differential western blot band pattern. As it appears
to be highly implausible that a transcription factor such as c-Jun
plays a role as a synaptically associated protein, the absence of
a band other than that for c-Jun in the western blots may be
due to the low levels of the Y172 synaptic antigen in spinal
cord extracts.
Y172-Immunolabeling in NSC-34 Cells and
Cultured MNs
We next analyzed whether Y172 immunoreactivity could also be
observed in in vitro models such as NSC-34 MN-like cells and
cultured CD1MNs. Due to the highly restrictive immunostaining
found with the Y172 antibody in MNs in vivo, a similar pattern
of immunolabeling in vitro could provide us enough protein for
purification and further analyses.
Differentiated NSC-34 cells resemble mature MNs based
on several morphological and physiological features (Cashman
et al., 1992; Matusica et al., 2008; Maier et al., 2013). Due
to the controversial data reported in the literature concerning
the use of RA in NSC-34 cell cultures to achieve greater
MN-like phenotypic properties (Johann et al., 2011; Maier
et al., 2013; Madji Hounoum et al., 2016), we decided to
maintain the cells in differentiation medium (DMEM/Ham’s
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FIGURE 10 | Changes in Y172 immunoreactivity in MNs from Smn2B/− mice. (A–C) The density (per 100 µm of cell body perimeter) of peripherally located
Y172-positive profiles (A) and of VAChT-positive puncta (B), and the percentage of VAChT-positive puncta spatially associated with Y172 immunoreactivity (C) in
mutant mouse MNs at different stages of disease (early presymptomatic [P1 and P5], late symptomatic [P20], and end-stage [P25–30]). (D1–E4) Representative
confocal micrographs of spinal cord sections from Smn2B/− mice at P25 immunostained with Y172 (green) and anti-VAChT (for C-boutons, red) antibodies, as
indicated in the panels; sections were also counterstained with fluorescent Nissl stain (blue in D4 and E4) for MN visualization. Note the intense nuclear
Y172 immunostaining in (D1,E1) and the marked depletion in Y172-positive profiles found in spinal muscular atrophy (SMA) MNs. The data are expressed as the
mean ± SEM; 15–20 MNs randomly selected from Smn2B/− mice and respective WT littermates were analyzed; **p < 0.01 and ***p < 0.001 vs. WT, student’s t-test.
Scale bars: D4 = 40 µm (valid for D1–D3); and E4 = 10 µm (valid for E1–E3).
F12) either containing or not containing RA. After 2–4 days of
differentiation, NSC-34 cells exhibited numerous and extensive
neurites that appeared more poorly developed in the presence
of RA (not shown). This observation is in agreement with
a previous study (Madji Hounoum et al., 2016), in which
authors showed that the addition of RA to DMEM/Ham’s
F12 medium, compared to the same differentiation medium
without RA, decreases the average neurite length. Western blot
analysis with the Y172 antibody revealed basal levels of p-c-
Jun-like protein in undifferentiated cells; at all the time-points
studied (after 2, 4 and 8 days of differentiation), the protein
expression levels increased in NSC-34 cells cultured without RA
but not in those maintained in its presence (Figures 12A,B).
Therefore, we chose NSC-34 cells cultured in the absence
of RA for our immunocytochemical studies. After 2 days of
differentiation, Y172 immunolabeling was located in the nucleus
of NSC-34 cells, and there was no detectable positivity into
the cell body cytoplasm (Figures 12C1–C4). After 4 days
of differentiation, nuclear Y172 immunostaining was reduced,
and some immunolabeled cytoplasmic spots were detected
(Figures 12D1–D4). After 8 days of differentiation, a drastic
decrease in the nuclear Y172 signal, which correlated with an
increase in cytoplasmic positive spots, was found in NSC-34 cells
(Figures 12E1–E4). Thus, in agreement with our observations
in CD1 MNs in vivo, NSC-34 cell differentiation resulted in a
progressive decrease in nuclear Y172 immunolabeling, which
was accompanied by a gradual emergence of positive cytoplasmic
spots. To explore whether Y172-immunoreactive spots in
differentiated NSC-34 cells display a spatial association with
VAChT-positive puncta, double immunofluorescence analysis
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FIGURE 11 | p-c-Jun-like immunodetection with antibodies other than
Y172 under basal conditions and in axotomized MNs (30 days after sciatic
nerve transection at P60). (A1–E4) Representative images of spinal cord MNs
double immunostained with different polyclonal antibodies (pAbs) against
c-Jun (green) phosphorylated at either Ser63 (A1–B4) or Ser73 (C1–E4) and
VAChT (red); fluorescent Nissl stain (blue in A4,B4,C4,D4, and E4) was used
to visualize MNs. The images in (A1,B1), which show the p-c-Jun (Ser63)
channel, were obtained following the modification of scanning parameters to
achieve a higher sensitivity of detection than that used for the Y172 antibody.
Note the absence of p-c-Jun (Ser63) nuclear immunostaining and the
presence of immunolabeled cytoplasmic profiles mainly located in the
periphery of the cell body (arrows in A3,A4) under basal conditions (A1–A4).
Thirty days after unilateral sciatic nerve transection (B1–B4), the same
antibody revealed prominent nuclear immunostaining in MNs located on the
ipsilateral (operated) side of the spinal cord (white arrow in B4) but an almost
complete absence of cytoplasmic positive profiles. The intense
immunoreactivity in the nucleus of the presumably axotomized MN was in
contrast with the faint nuclear immunostaining in the neighboring neuron,
likely corresponding to a nonlesioned MN (blue arrow in B4). (C1–C4)
Negative immunostaining with the polyclonal antibody against p-c-Jun
(Ser73) was observed in both the nucleus and cytoplasm of an MN under
basal conditions. (D1–E4) The same antibody showed intense positive
nuclear immunostaining and the absence of immunostained cytoplasmic
profiles in axotomized MNs, both in the ipsilateral and contralateral side of the
spinal cord. (F) Representative western blots of mouse spinal
(Continued)
FIGURE 11 | Continued
cord extracts probed with the antibodies against p-c-Jun used in our study; a
monoclonal antibody against c-Jun (c-Jun mAb) was also included, and
β-actin was used as a loading control. Note that a band corresponding to
∼43–48 kDa, as expected for p-c-Jun, was observed; the same band was
also seen in western blots performed with the anti-c-Jun antibody. (G)
Densitometric analysis of p-c-Jun bands obtained in western blots by probing
with the antibodies used for analysis. The data were normalized to β-actin;
the bars represent the values (mean ± SEM) of extracts from three mice.
Scale bar: E4 = 20 µm (valid for A1–E3).
with Y172 and anti-VAChT antibodies were performed. After
2 days of differentiation, VAChT-immunostaining was already
present in NSC-34 cells in the form of a weakly positive diffuse
staining distributed in the cytoplasm; no clear and defined
concentrations of VAChT-positive puncta were observed in the
periphery of cell bodies or proximal dendrites. This pattern
of VAChT immunostaining remained unchanged after 4 and
8 days of cell differentiation. This finding is consistent with
previous reports (Maier et al., 2013) and indicates the inability
of differentiated NSC-34 cells to establish cholinergic synapses.
In any case, no consistent spatial association was observed
between the Y172-positive and VAChT-positive cytoplasmic
spots in differentiated NSC-34 cells on any of the days in vitro
(DIV) examined.
We next analyzed p-c-Jun-like protein expression with
the Y172 antibody in cultured spinal cord MNs. MNs from
E13 CD1 mice were collected 3, 6, and 12 days after seeding
and processed for immunocytochemistry and western blot
analysis (Figures 12F–K4). In MNs cultured for 3 days,
prominent nuclear immunostaining was detected in virtually
all MNs; conversely, their cytoplasm exhibited faint and diffuse
Y172 positivity (Figures 12H1–H4). After 6 DIV, cytoplasmic
Y172 immunostaining increased, and several oval patches
distributed throughout the soma and proximal dendrites, such
as those observed in vivo in adult CD1 mice MNs, were
seen (Figures 12I1–I4). Unlike those in NSC-34 cells, some
Y172-positive patches displayed a close spatial relationship
with VAChT-positive puncta, which were distributed in the
cell body and neurites of cultured MNs. After 12 DIV, a
diminished density of Y172-positive cytoplasmic spots was
observed (Figures 12J1–K4). These findings are consistent with
the western blot analysis data showing higher levels of p-c-
Jun-like protein expression in cultured MNs after 6 DIV and
a subsequent moderate decrease at 12 DIV (Figures 12F,G).
These results suggest that primary cultured MNs provide an
appropriate paradigm to further examine the specificity of
Y172 immunostaining.
Because C-bouton-like synapses arise from cholinergic
interneurons and because astroglial cells improve MN viability
in vitro, we also used mixed primary spinal cord cultures
from CD1 mice in which both MNs and interneurons were
grown on a bed of astroglial cells (Roy et al., 1998). We
proposed this type of culture to be more suitable for the
development of C-bouton-like synapses arising from cholinergic
interneurons, which we believed to be virtually present in
these mixed neuronal cultures. MNs were identified by their
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FIGURE 12 | Western blot and immunocytochemical analyses with the Y172 antibody in NSC-34 cells (A–E4) and cultured MNs (F–K4). (A) The time course of
Y172 antigen expression levels in NSC-34 cells after a different number of days (0, 2, 4 and 8) (d) of differentiation, as determined by western blot analysis; the
densitometric analysis was normalized to β-actin, which was used as a loading control. (B) Representative western blots of NSC-34 cells probed with the
Y172 antibody used for quantification in (A). (C1–E4) Representative confocal images of NSC-34 cells after 2 (C1–C4), 4 (D1–D4) and 8 (E1–E4) days of
differentiation stained with Y172 (green) and anti-VAChT (red) antibodies as well as DAPI (blue) for DNA, as indicated. Y172 immunostaining was found exclusively in
the nuclei of NSC-34 cells following 2 days of differentiation (C1–4); however, granular immunostaining was observed in the cytoplasm of cell bodies and neurites
after 4 days of differentiation (D1–4); after 8 days of differentiation, Y172 immunostaining decreased in the nucleus but markedly increased in the cytoplasm of cell
bodies and proximal neurites (E1–4). VAChT immunostaining displayed a diffuse and faintly positive pattern into the cell body cytoplasm, and although some positive
puncta appear to be present, these were very scarce and did not have a defined location in NSC-34 cells. (F) The time course of Y172 antigen expression levels in
MNs cultured for 3, 6 and 12 days, determined by western blot analysis; the densitometric analysis was normalized to β-actin, which was used as a loading control.
(G) Representative western blots of cultured MNs probed with the Y172 antibody used for quantification in (F). (H1–K4) Representative confocal images of MNs
cultured for 3 (H1–4), 6 (I1–4) and 12 (J1–4) days stained with Y172 (green) and anti-VAChT (red) antibodies as well as DAPI (blue) for DNA, as indicated. Note the
intense nuclear positivity but the faint and discrete cytoplasmic signal obtained with the Y172 antibody at 3 DIV (H1–4); however, at 6 DIV (I1–I4), an increase in the
cytoplasmic immunolabeling, mainly in the form of oval patches in the soma and proximal neurites, was observed. Following 12 days of culture (J1–4), a reduction in
Y172 immunolabeling was observed in the cytoplasm, although some positive profiles remained. The area delimited by the dotted rectangle in (J1–J4) is shown in
(K1–K4) at higher magnification; note that some Y172-positive profiles were in close association with patches expressing VAChT (red, arrow). The data in (A,F) are
shown as the mean ± SEM of 3–6 western blots from three independent cultures. Scale bars: E4,J4 = 20 µm (valid for C1-E3,H1–J3, respectively); K4 = 4 µm
(valid for K1–K3).
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large size and ChAT immunoreactivity and were maintained
as apparently healthy cells for 22–25 DIV. Some MNs showed
nuclear Y172 immunofluorescence (Supplementary Figures
S4A1–A3), in agreement with the pattern of immunolabeling
observed with the antibody in vitro in purified MNs, as well as
in vivo in MNs. In addition, some MNs displayed peripheral
Y172-positive profiles similar to those observed in vitro in
purified MNs and in vivo in MNs from the spinal cord
(Supplementary Figures S4B1–B3; the number of MNs with
Y172-positive peripheral clusters: 12.42% ± 3.05, 12,578 MNs
analyzed from 10 cultures maintained for 18–20 DIV). The
presence of peripherally located Y172-positive profiles in these
MNs was not always associated with nuclear immunolabeling
with the Y172 antibody. Interestingly, in contrast to
our observations in vivo, the vast majority of peripheral
Y172-positive profiles in MNs did not appear to be associated
with the synaptic marker synaptophysin (Supplementary
Figures S4C1–C4); conversely, puncta positive for both
Y172 and synaptophysin exhibited a close relationship with
VAChT-positive puncta (Supplementary Figures S4D1–D4).
Furthermore, electron microscopy examination of cultures
using pre-embedding immunolabeling showed clusters of
Y172 immunoreactivity at the plasma membrane, frequently
without facing synapses (Supplementary Figure S4E). In some
cases, however, these Y172-positive profiles were associated
with presynaptic, presumably C-type, boutons (Supplementary
Figure S4F). Y172 immunoreactivity was also detected in
different regions of the MN cytoplasm.
Downregulation of Y172 Immunostaining in
Cultured MNs After a c-Jun Knockdown by
RNA Interference
RNA interference allows the silencing of gene expression at the
posttranscriptional level in a sequence-specific manner and is
widely used for the analysis of gene function (Dykxhoorn et al.,
2003). We applied this procedure to knock down c-Jun in vitro
and analyze whether the Y172 antibody indeed detects p-c-Jun
or cross-reacts with another protein. For this, we generated
three different lentiviral vectors, each one of which contained
a different shRNA (A6 shRNA, B4 shRNA, and C2 shRNA,
referred to as A6, B4 and C2, respectively) targeting a specific
site of the c-Jun mouse sequence and transduced purified
cultured MNs. The c-Jun shRNA knockdown efficiency was
determined by western blot analysis with the Y172 antibody
(Figure 13A). We found that, 6 days after transduction,
compared to the EV control, the A6 and B4 shRNAs, but not
the C2 shRNA, decreased p-c-Jun-like levels (% reduction: A6,
∼40%; B4,∼80%), although the reduction obtained with A6 was
not statistically significant (Figure 13B). We next examined
Y172 antibody immunofluorescence to determine whether the
p-c-Jun-like expression is also reduced in cultured cells after
construct transduction. Compared to the percentage in cultures
transduced with EV, the percentage of MNs exhibiting p-c-Jun-
like-positivity in cultures transduced with shRNA vectors was
lower (% decrease compared to EV: A6,∼6%, B4,∼20% and C2,
∼8%). We then assessed whether MNs still showing p-c-Jun-like
expression following shRNA transduction experience a loss
of nuclear or cytoplasmic Y172 immunofluorescence. We
found that, compared to EV-transduced cultures, A6- and
B4-transduced cultures had lower numbers of cells exhibiting
nuclear Y172 positivity (A6, ∼15% and B4, ∼62%, reduction
vs. EV), even though the decrease obtained with A6 was
not statistically significant. No changes were observed in
C2-transduced cultures (Figures 13C,D1–K). Next, we analyzed
whether our shRNA vectors were also able to decrease
cytoplasmic Y172 immunolabeling. No reduction in the number
of MNs showing cytoplasmic immunostaining was observed for
either of the shRNA vectors used. Therefore, B4 was the only
shRNA tested that was able to induce a significant reduction in
nuclear Y172 immunoreactivity. This result is supported by the
finding that B4 was also the most efficient shRNA in decreasing
the levels of p-c-Jun-like expression, as detected by western
blot analysis with the Y172 antibody. As none of the tested
shRNAs against c-Jun appeared to be able to induce a reduction
in both nuclear and cytoplasmic Y172 immunoreactivity, we
assume that the Y172 antibody detects a synaptic protein
other than p-c-Jun.
DISCUSSION
The C-bouton synapse is presently gaining considerable interest
due to recent insights into the knowledge of its complex
molecular organization, its association with ER-PM contacts
and its involvement in MN pathology (Deardorff et al.,
2014; Witts et al., 2014; Salvany et al., 2019). In previous
studies, we reported that the NRG1-ErbBs signaling module
concentrates at C-boutons and compartmentalizes and associates
with different proteins previously known to be expressed in
these synapses, such as S1R and Kv2.1 (Gallart-Palau et al.,
2014; Casanovas et al., 2017). We noticed that these proteins,
along with NRG1, are located in segregated regions inside
the SSCs of C-boutons, which apparently represent highly
restricted spatial microdomains (Casanovas et al., 2017). We
also described that MN activity and peripheral nerve injury
induce important changes in the C-bouton organization and
provoke the noticeable loss of NRG1 clusters in SSCs (Salvany
et al., 2019). Here, we show a novel unidentified molecular
component of the C-bouton organization. By means of a
monoclonal antibody (clone Y172) against p-c-Jun (Ser63), we
described a selective immunocytochemical pattern in adult MNs
that differs from what is normally expected for a transcription
factor. We found that developing or injured adult MNs displayed
strong nuclear Y172 immunostaining that is consistent with
the expected nuclear expression of p-c-Jun previously reported
under these conditions (Sun et al., 2005; Yuan et al., 2010).
In contrast, normal adult MNs showed intense Y172 positivity
in structures scattered in the cell body cytoplasm. We noticed
that the vast majority of Y172-positive patches peripherally
located in the cell body and proximal dendrites were closely
associated with C-boutons but not with other types of synaptic
afferents projecting to MNs (e.g., glutamatergic or GABAergic
inputs). Remarkably, by electron microscopy, it was found that
cytoplasmic Y172 immunolabeling was selectively located in
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FIGURE 13 | c-Jun knockdown by using shRNAs. (A) Representative western blots of cultured MNs transduced with EV, A6, B4, and C2 shRNAs probed with the
Y172 antibody; β-actin was used as a loading control. (B) Densitometric analysis (expressed as arbitrary units) of western blots probed with the Y172 antibody and
normalized to β-actin. The data are shown as the mean ± SEM of four western blots from two independent experiments; *p < 0.05, one-way ANOVA, Bonferroni’s
post hoc test. (C) The number of MNs (expressed as the percentage of EV) exhibiting Y172-positive immunostaining in the nucleus (Nucl.) and cell body cytoplasm
(cyto.) of cultured MNs after either A6, B4 or C2 transduction. (D1–G1) Representative images of cultured MNs (GFP, green) transduced with either EV (D1–D4), A6
(E1–E4), B4 (F1–F4) or C2 (G1–G4) shRNAs and processed for Y172 immunostaining (red) and DAPI staining (for DNA staining, blue). (H–K) High magnification
images of the Y172 channel of the areas delimited by dotted-line rectangles in (D4–G4) are shown in (H–K), respectively. Note the reduction in nuclear, but not
cytoplasmic, Y172 immunoreactivity in the B4-transduced MN shown in (J) compared to the non-transduced MN shown in (H). The data in the graphs are
expressed as the mean ± SEM; *p < 0.05 and ***p < 0.001 vs. EV, one-way ANOVA, Bonferroni’s post hoc test; n = 4. Scale bar: G4 = 20 µm (valid for D1–G3);
K = 10 µm (valid for H–J).
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SSCs and specific domains of the secretory pathway, particularly
in areas of stacked ER cisterns and Golgi-related vesicles.
Moreover, MNs from NRG1 type III-overexpressing transgenic
mice, in which SSCs are abnormally expanded (Salvany et al.,
2019), displayed more abundant and larger Y172-positive
profiles than those exhibited by normal MNs, confirming
their association with SSC-like organelles. Additionally, we
also showed that, in adult mice, peripheral nerve injury
results in a noticeable decrease in the density and size of
cytoplasmic Y172-positive profiles in axotomized MNs, and
that this decrease is dissociated from the time course of
C-bouton loss observed under this experimental condition
(Salvany et al., 2019). Furthermore, in SOD1G93A and Smn2B/−
mutant mice, which mimic the human MN diseases ALS
and SMA, respectively, degenerating MNs exhibit increased
nuclear Y172 immunoreactivity, indicative of c-Jun activation
in injured MNs, but a marked depletion in C-bouton-
associated Y172-positive profiles, which is consistent with the
loss of afferent inputs that occurs in MN diseases (Ling
et al., 2010; Mentis et al., 2011; Moreno-López et al., 2011;
Sunico et al., 2011; Tarabal et al., 2014; Milan et al., 2015;
Cerveró et al., 2018).
Cholinergic synapses and C-boutons barely develop in
cultured MNs; we reported here that most of the scarce
cholinergic synapses that developed in vitro displayed
Y172 immunostaining. However, in concordance with our
previous data on NRG1 (Casanovas et al., 2017), many MN
surface-associated Y172-positive patches were not related to
synaptic boutons. These data confirm that the Y172 antigen
has an in vitro developmental profile analogous to that of other
C-bouton-associated proteins.
Our serendipitous finding of the close association between
cytoplasmic structures specifically immunolabeled with the
Y172 antibody and C-boutons prompted us to analyze whether
the antibody crossreacts with an epitope that belongs to a
protein other than p-c-Jun. It should be noted that only
antibodies recognizing p-c-Jun (Ser63) displayed C-bouton
labeling. However, in western blot analyses of spinal cord
extracts, we did not find significant differences between p-c-
Jun (Ser63) and (Ser73) antibodies. Therefore, we conclude that
the synaptic-specific protein detected by the Y172 antibody
was not identified by western blot, probably due to its scarce
representation in the whole spinal cord extracts used for the
analysis. In fact, MNs represent less than 10% of the neuronal
population of the spinal cord (Arce et al., 1999), and we
estimated that C-boutons do not constitute more than ∼4%
of total MN afferent synapses. We think that only highly
selective sampling procedures, which are beyond the scope
of this work, can address the molecular identification of the
Y172 binding epitope in MNs. In any case, the Y172 antibody
should be considered a new specific marker for C-boutons to
be used in future developments. In fact, it is not uncommon
that a monoclonal antibody binds to an antigen different from
the one that it has been raised against. For instance, the
CC1 monoclonal antibody widely used as an oligodendrocyte-
specific marker was originally developed against adenomatous
polyposis coli (APC), a protein that, oddly, is not present
in oligodendrocytes; instead, CC1 binds to the more recently
discovered target Quaking 7 in oligodendrocytes (Bin et al.,
2016). Another possibility that should not be ignored is that the
c-Jun gene encodes, by alternative splicing, a yet unidentified
tissue-specific protein associated with ER-PM contacts. In this
regard, ribbon synapse (RIBEYE), a new identified protein
specifically located in retina ribbon synapse, is encoded by
the same gene as CtBP2, the CtBP2/RIBEYE gene, when an
alternative promoter is used. CtBP2 is a transcriptional repressor
ubiquitously expressed, whereas RIBEYE is expressed in a tissue-
specific fashion and is involved in synaptic vesicle transport and
exocytosis (Piatigorsky, 2001). Additionally, the transcription
factor fused in sarcoma (FUS), which is normally located in
the nucleus, has also been reported to be present at synaptic
compartments (Schoen et al., 2016). Nevertheless, in our RNA
interference experiments, we were able to significantly reduce
Y172 immunostaining in the nucleus but not in the cytoplasm
of cultured MNs by using different shRNA vectors targeting
specific sites of the c-Jun mouse sequence. This suggests that,
with high probability, the Y172 antibody selectively binds
an unidentified protein other than p-c-Jun that is located at
the postsynaptic compartment of C-boutons. In any case, the
results reported here pave the way for future studies aimed at
identifying and characterizing the synaptic protein recognized
by the Y172 antibody and at further exploring its role in
the context of the development, maintenance, plasticity and
pathology of C-boutons.
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